ID,Gene_name,Variant_effect,ELMIdentifier,startstop,comm,Accession,FunctionalSiteName,Description,Regex,Probability,#Instances,#Instances_in_PDB
rs544407865,RBM20,missense,LIG_WD40_WDR5_VDV_2,804-811,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs544407865,RBM20,missense,LIG_WD40_WDR5_VDV_2,805-811,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200762526,F5,missense,LIG_WD40_WDR5_VDV_2,1364-1370,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200762526,F5,missense,LIG_WD40_WDR5_VDV_2,1365-1370,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200762526,F5,missense,LIG_WD40_WDR5_VDV_2,1367-1370,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs536528003,MYO7A,missense,LIG_WD40_WDR5_VDV_2,1944-1949,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572315698,IL17RD,missense,LIG_WD40_WDR5_VDV_2,90-96,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs183729115,RET,missense,LIG_WD40_WDR5_VDV_2,396-402,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201859063,ALAD,missense,LIG_WD40_WDR5_VDV_2,295-298,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs147415451,DSP,missense,LIG_WD40_WDR5_VDV_2,1722-1729,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs147415451,DSP,missense,LIG_WD40_WDR5_VDV_2,1723-1729,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs567185914,CEP290,missense,LIG_WD40_WDR5_VDV_2,1105-1111,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs372505798,MYH7B,missense,LIG_WD40_WDR5_VDV_2,1243-1250,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs372505798,MYH7B,missense,LIG_WD40_WDR5_VDV_2,1244-1250,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs372505798,MYH7B,missense,LIG_WD40_WDR5_VDV_2,1246-1252,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs374655803,MYO7A,missense,LIG_WD40_WDR5_VDV_2,1666-1673,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs374655803,MYO7A,missense,LIG_WD40_WDR5_VDV_2,1668-1673,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs548208395,SLC26A4,missense,LIG_WD40_WDR5_VDV_2,573-577,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs575447822,CPT2,missense,LIG_WD40_WDR5_VDV_2,405-412,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs575447822,CPT2,missense,LIG_WD40_WDR5_VDV_2,406-412,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs575447822,CPT2,missense,LIG_WD40_WDR5_VDV_2,407-412,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs575447822,CPT2,missense,LIG_WD40_WDR5_VDV_2,408-412,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs575447822,CPT2,missense,LIG_WD40_WDR5_VDV_2,409-412,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs545466982,NOD2,missense,LIG_WD40_WDR5_VDV_2,425-432,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs143273384,ATP2B3,missense,LIG_WD40_WDR5_VDV_2,497-503,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs577827394,STX11,missense,LIG_WD40_WDR5_VDV_2,109-116,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs577827394,STX11,missense,LIG_WD40_WDR5_VDV_2,111-116,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs577827394,STX11,missense,LIG_WD40_WDR5_VDV_2,112-116,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs567877611,RET,missense,LIG_WD40_WDR5_VDV_2,104-111,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs567877611,RET,missense,LIG_WD40_WDR5_VDV_2,105-111,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs567877611,RET,missense,LIG_WD40_WDR5_VDV_2,107-111,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs531537646,LAMA1,missense,LIG_WD40_WDR5_VDV_2,694-700,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs531537646,LAMA1,missense,LIG_WD40_WDR5_VDV_2,695-700,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs531537646,LAMA1,missense,LIG_WD40_WDR5_VDV_2,699-706,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150140303,IL10RA,missense,LIG_WD40_WDR5_VDV_2,25-32,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150399299,BBS9,missense,LIG_WD40_WDR5_VDV_2,543-550,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150399299,BBS9,missense,LIG_WD40_WDR5_VDV_2,545-550,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs539346540,LRP5,missense,LIG_WD40_WDR5_VDV_2,127-134,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs539346540,LRP5,missense,LIG_WD40_WDR5_VDV_2,128-134,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs539346540,LRP5,missense,LIG_WD40_WDR5_VDV_2,129-134,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs558414868,CEP290,missense,LIG_WD40_WDR5_VDV_2,459-465,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs558414868,CEP290,missense,LIG_WD40_WDR5_VDV_2,460-465,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs372585344,NEK1,missense,LIG_WD40_WDR5_VDV_2,379-384,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141722672,BAAT,missense,LIG_WD40_WDR5_VDV_2,227-234,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs142293185,MYO7A,missense,LIG_WD40_WDR5_VDV_2,1951-1956,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs190761354,ABCC6,missense,LIG_WD40_WDR5_VDV_2,590-596,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs376320828,CEP290,missense,LIG_WD40_WDR5_VDV_2,660-667,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs376320828,CEP290,missense,LIG_WD40_WDR5_VDV_2,664-667,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs142648132,MTR,missense,LIG_WD40_WDR5_VDV_2,242-248,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs540014314,RBM20,missense,LIG_WD40_WDR5_VDV_2,1012-1019,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs540014314,RBM20,missense,LIG_WD40_WDR5_VDV_2,1013-1019,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs540014314,RBM20,missense,LIG_WD40_WDR5_VDV_2,1014-1019,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs540014314,RBM20,missense,LIG_WD40_WDR5_VDV_2,1015-1019,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs34150427,KCNQ1,missense,LIG_WD40_WDR5_VDV_2,647-652,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs139719799,BBS10,missense,LIG_WD40_WDR5_VDV_2,550-557,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs562225614,NOD2,missense,LIG_WD40_WDR5_VDV_2,425-432,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs143994626,DSP,missense,LIG_WD40_WDR5_VDV_2,317-321,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs567750476,BBS9,missense,LIG_WD40_WDR5_VDV_2,747-754,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs149518451,OTUD4,missense,LIG_WD40_WDR5_VDV_2,843-850,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs149518451,OTUD4,missense,LIG_WD40_WDR5_VDV_2,845-850,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs149518451,OTUD4,missense,LIG_WD40_WDR5_VDV_2,846-850,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs571621861,CEP290,missense,LIG_WD40_WDR5_VDV_2,422-429,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs571621861,CEP290,missense,LIG_WD40_WDR5_VDV_2,424-429,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200308684,SLC45A2,missense,LIG_WD40_WDR5_VDV_2,363-369,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200308684,SLC45A2,missense,LIG_WD40_WDR5_VDV_2,364-369,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs309369,BBS12,missense,LIG_WD40_WDR5_VDV_2,124-130,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs309369,BBS12,missense,LIG_WD40_WDR5_VDV_2,125-130,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs309369,BBS12,missense,LIG_WD40_WDR5_VDV_2,126-130,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs199989979,MYO7A,missense,LIG_WD40_WDR5_VDV_2,13-16,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs1127291,LRP5,missense,LIG_WD40_WDR5_VDV_2,1518-1525,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs1127291,LRP5,missense,LIG_WD40_WDR5_VDV_2,1519-1525,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs535296791,PRF1,missense,LIG_WD40_WDR5_VDV_2,140-147,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs535296791,PRF1,missense,LIG_WD40_WDR5_VDV_2,141-147,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs373552185,DFNB31,missense,LIG_WD40_WDR5_VDV_2,730-735,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs373552185,DFNB31,missense,LIG_WD40_WDR5_VDV_2,731-735,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs373552185,DFNB31,missense,LIG_WD40_WDR5_VDV_2,732-735,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs373552185,DFNB31,missense,LIG_WD40_WDR5_VDV_2,734-740,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs139853866,OCA2,missense,LIG_WD40_WDR5_VDV_2,450-456,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs139853866,OCA2,missense,LIG_WD40_WDR5_VDV_2,453-456,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150062967,LRRK2,missense,LIG_WD40_WDR5_VDV_2,2488-2495,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150062967,LRRK2,missense,LIG_WD40_WDR5_VDV_2,2491-2495,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs17466213,LRRK2,missense,LIG_WD40_WDR5_VDV_2,1366-1373,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs17466213,LRRK2,missense,LIG_WD40_WDR5_VDV_2,1368-1373,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs4640000,LRRK2,missense,LIG_WD40_WDR5_VDV_2,1259-1264,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs546641348,SCN1A,missense,LIG_WD40_WDR5_VDV_2,166-173,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs546641348,SCN1A,missense,LIG_WD40_WDR5_VDV_2,168-173,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs546641348,SCN1A,missense,LIG_WD40_WDR5_VDV_2,169-173,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs61754402,PRPH2,missense,LIG_WD40_WDR5_VDV_2,9-16,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs548101215,UNC13D,missense,LIG_WD40_WDR5_VDV_2,704-710,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs548101215,UNC13D,missense,LIG_WD40_WDR5_VDV_2,706-710,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs183443251,MYO7A,missense,LIG_WD40_WDR5_VDV_2,345-352,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs397516293,MYO7A,missense,LIG_WD40_WDR5_VDV_2,704-711,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150924946,LMNA,missense,LIG_WD40_WDR5_VDV_2,295-299,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs61747727,NPHS2,missense,LIG_WD40_WDR5_VDV_2,240-247,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201991154,MTR,missense,LIG_WD40_WDR5_VDV_2,1131-1136,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs532380776,STXBP2,missense,LIG_WD40_WDR5_VDV_2,66-73,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs138072724,BBS9,missense,LIG_WD40_WDR5_VDV_2,425-432,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs568913937,POLG,missense,LIG_WD40_WDR5_VDV_2,629-634,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs371316424,LRRK2,missense,LIG_WD40_WDR5_VDV_2,770-777,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201107567,NOD2,missense,LIG_WD40_WDR5_VDV_2,351-358,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs112194576,LAMA1,missense,LIG_WD40_WDR5_VDV_2,219-226,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs112194576,LAMA1,missense,LIG_WD40_WDR5_VDV_2,220-226,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs104895447,NOD2,missense,LIG_WD40_WDR5_VDV_2,862-866,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200270332,LAMB3,missense,LIG_WD40_WDR5_VDV_2,1013-1018,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs138731082,DFNB31,missense,LIG_WD40_WDR5_VDV_2,876-883,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150880478,TTC8,missense,LIG_WD40_WDR5_VDV_2,92-96,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150880478,TTC8,missense,LIG_WD40_WDR5_VDV_2,93-96,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs147500559,DFNB31,missense,LIG_WD40_WDR5_VDV_2,358-365,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs188516326,DSP,missense,LIG_WD40_WDR5_VDV_2,86-93,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201234008,NPHS1,missense,LIG_WD40_WDR5_VDV_2,251-257,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201234008,NPHS1,missense,LIG_WD40_WDR5_VDV_2,252-257,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs369286165,LAMA1,missense,LIG_WD40_WDR5_VDV_2,1204-1208,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs369286165,LAMA1,missense,LIG_WD40_WDR5_VDV_2,1207-1214,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201779301,LRP5,missense,LIG_WD40_WDR5_VDV_2,435-442,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201779301,LRP5,missense,LIG_WD40_WDR5_VDV_2,437-442,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201779301,LRP5,missense,LIG_WD40_WDR5_VDV_2,438-442,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs191807913,NPHS1,missense,LIG_WD40_WDR5_VDV_2,671-678,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs199552001,LRRK2,missense,LIG_WD40_WDR5_VDV_2,293-298,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200139879,SLC26A4,missense,LIG_WD40_WDR5_VDV_2,93-100,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200139879,SLC26A4,missense,LIG_WD40_WDR5_VDV_2,94-100,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs551068385,SCN1A,missense,LIG_WD40_WDR5_VDV_2,208-214,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs551593576,LRRK2,missense,LIG_WD40_WDR5_VDV_2,575-582,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs551593576,LRRK2,missense,LIG_WD40_WDR5_VDV_2,578-582,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs559363120,PYGM,missense,LIG_WD40_WDR5_VDV_2,732-739,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs559363120,PYGM,missense,LIG_WD40_WDR5_VDV_2,733-739,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs559363120,PYGM,missense,LIG_WD40_WDR5_VDV_2,734-739,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs557802902,BBS10,missense,LIG_WD40_WDR5_VDV_2,215-221,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs557802902,BBS10,missense,LIG_WD40_WDR5_VDV_2,216-221,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs546815467,SCN5A,missense,LIG_WD40_WDR5_VDV_2,1867-1873,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs546815467,SCN5A,missense,LIG_WD40_WDR5_VDV_2,1869-1873,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs202157653,LAMA1,missense,LIG_WD40_WDR5_VDV_2,567-574,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs202157653,LAMA1,missense,LIG_WD40_WDR5_VDV_2,568-574,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs559720365,TYR,missense,LIG_WD40_WDR5_VDV_2,137-140,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs546272425,LMNA,missense,LIG_WD40_WDR5_VDV_2,300-304,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs546272425,LMNA,missense,LIG_WD40_WDR5_VDV_2,301-304,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs58073789,ABCC6,missense,LIG_WD40_WDR5_VDV_2,723-728,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs556728426,NOD2,missense,LIG_WD40_WDR5_VDV_2,448-454,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs556728426,NOD2,missense,LIG_WD40_WDR5_VDV_2,449-454,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs528755232,CDH23,missense,LIG_WD40_WDR5_VDV_2,542-549,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs528755232,CDH23,missense,LIG_WD40_WDR5_VDV_2,543-549,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs528755232,CDH23,missense,LIG_WD40_WDR5_VDV_2,544-549,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs45496496,MYH7,missense,LIG_WD40_WDR5_VDV_2,958-964,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs45496496,MYH7,missense,LIG_WD40_WDR5_VDV_2,960-964,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs199629447,F5,missense,LIG_WD40_WDR5_VDV_2,2211-2218,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs72549382,CYP1B1,missense,LIG_WD40_WDR5_VDV_2,318-324,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs536585114,SCN5A,missense,LIG_WD40_WDR5_VDV_2,1152-1157,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs180723721,BBS12,missense,LIG_WD40_WDR5_VDV_2,110-115,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs377651588,COL17A1,missense,LIG_WD40_WDR5_VDV_2,399-406,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs377651588,COL17A1,missense,LIG_WD40_WDR5_VDV_2,400-406,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs371080525,MITF,missense,LIG_WD40_WDR5_VDV_2,104-109,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs371080525,MITF,missense,LIG_WD40_WDR5_VDV_2,105-109,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs5743272,NOD2,missense,LIG_WD40_WDR5_VDV_2,351-358,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs34320941,KCNQ1,missense,LIG_WD40_WDR5_VDV_2,295-302,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs190624231,MYO7A,missense,LIG_WD40_WDR5_VDV_2,704-711,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs528175399,BBS12,missense,LIG_WD40_WDR5_VDV_2,110-115,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs183387506,CEP290,missense,LIG_WD40_WDR5_VDV_2,2357-2364,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs61736659,PYGM,missense,LIG_WD40_WDR5_VDV_2,647-653,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs61736659,PYGM,missense,LIG_WD40_WDR5_VDV_2,649-653,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs549351523,LRRK2,missense,LIG_WD40_WDR5_VDV_2,1011-1018,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs549351523,LRRK2,missense,LIG_WD40_WDR5_VDV_2,1014-1018,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs111369324,UROD,missense,LIG_WD40_WDR5_VDV_2,119-126,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs148682262,BMPR2,missense,LIG_WD40_WDR5_VDV_2,224-231,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141796804,LRP5,missense,LIG_WD40_WDR5_VDV_2,690-696,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141796804,LRP5,missense,LIG_WD40_WDR5_VDV_2,692-696,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141796804,LRP5,missense,LIG_WD40_WDR5_VDV_2,693-696,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572512491,MYOC,missense,LIG_WD40_WDR5_VDV_2,442-449,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572512491,MYOC,missense,LIG_WD40_WDR5_VDV_2,443-449,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572512491,MYOC,missense,LIG_WD40_WDR5_VDV_2,444-449,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572512491,MYOC,missense,LIG_WD40_WDR5_VDV_2,446-449,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201326686,MYH7,missense,LIG_WD40_WDR5_VDV_2,1554-1561,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201326686,MYH7,missense,LIG_WD40_WDR5_VDV_2,1555-1561,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs541165691,LRP5,missense,LIG_WD40_WDR5_VDV_2,690-696,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs541165691,LRP5,missense,LIG_WD40_WDR5_VDV_2,692-696,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs541165691,LRP5,missense,LIG_WD40_WDR5_VDV_2,693-696,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs550276189,DFNB31,missense,LIG_WD40_WDR5_VDV_2,876-883,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs144968313,UNC13D,missense,LIG_WD40_WDR5_VDV_2,843-848,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs375201461,IL10RA,missense,LIG_WD40_WDR5_VDV_2,563-568,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs375201461,IL10RA,missense,LIG_WD40_WDR5_VDV_2,564-568,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs569786610,DSP,missense,LIG_WD40_WDR5_VDV_2,1355-1362,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs569786610,DSP,missense,LIG_WD40_WDR5_VDV_2,1356-1362,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs569786610,DSP,missense,LIG_WD40_WDR5_VDV_2,1357-1362,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200511789,SLC26A4,missense,LIG_WD40_WDR5_VDV_2,485-490,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200511789,SLC26A4,missense,LIG_WD40_WDR5_VDV_2,489-496,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs574535283,BAAT,missense,LIG_WD40_WDR5_VDV_2,227-234,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs542258150,PINK1,missense,LIG_WD40_WDR5_VDV_2,493-500,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs577724923,BBS9,missense,LIG_WD40_WDR5_VDV_2,243-248,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs573218837,IL17RD,missense,LIG_WD40_WDR5_VDV_2,598-605,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs573218837,IL17RD,missense,LIG_WD40_WDR5_VDV_2,599-605,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs573218837,IL17RD,missense,LIG_WD40_WDR5_VDV_2,600-607,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs117225191,LAMA1,missense,LIG_WD40_WDR5_VDV_2,2137-2144,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs117225191,LAMA1,missense,LIG_WD40_WDR5_VDV_2,2139-2144,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs117225191,LAMA1,missense,LIG_WD40_WDR5_VDV_2,2141-2144,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs142170797,TYR,missense,LIG_WD40_WDR5_VDV_2,305-312,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs563952288,PCDH15,missense,LIG_WD40_WDR5_VDV_2,578-583,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs563952288,PCDH15,missense,LIG_WD40_WDR5_VDV_2,579-583,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs149476106,MTR,missense,LIG_WD40_WDR5_VDV_2,1188-1195,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs554810939,BAAT,missense,LIG_WD40_WDR5_VDV_2,227-234,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs527378833,CHD7,missense,LIG_WD40_WDR5_VDV_2,44-50,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs140406696,PRPH2,missense,LIG_WD40_WDR5_VDV_2,276-281,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs115148599,F5,missense,LIG_WD40_WDR5_VDV_2,1432-1438,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs115148599,F5,missense,LIG_WD40_WDR5_VDV_2,1434-1438,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs115148599,F5,missense,LIG_WD40_WDR5_VDV_2,1437-1442,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572609043,DFNB31,missense,LIG_WD40_WDR5_VDV_2,647-654,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572609043,DFNB31,missense,LIG_WD40_WDR5_VDV_2,648-654,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572609043,DFNB31,missense,LIG_WD40_WDR5_VDV_2,651-654,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs557302067,MYO7A,missense,LIG_WD40_WDR5_VDV_2,349-355,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs557302067,MYO7A,missense,LIG_WD40_WDR5_VDV_2,351-358,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs34010619,OCA2,missense,LIG_WD40_WDR5_VDV_2,329-336,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs34010619,OCA2,missense,LIG_WD40_WDR5_VDV_2,332-336,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs543985400,USH1C,missense,LIG_WD40_WDR5_VDV_2,247-254,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs543985400,USH1C,missense,LIG_WD40_WDR5_VDV_2,249-254,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs146444716,CD2AP,missense,MOD_CK1_1,553-559,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs535041963,OTUD4,missense,MOD_CK1_1,1004-1010,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs41313697,SCN5A,missense,MOD_CK1_1,457-463,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs183518211,BMPR2,missense,MOD_CK1_1,568-574,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs183518211,BMPR2,missense,MOD_CK1_1,571-577,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs201690512,OTUD4,missense,MOD_CK1_1,563-569,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs188371821,BBS9,missense,MOD_CK1_1,256-262,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs200500057,LAMA1,missense,MOD_CK1_1,404-410,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs575447822,CPT2,missense,MOD_CK1_1,408-414,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs200770952,BBS7,missense,MOD_CK1_1,288-294,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs143119752,IL17RD,missense,MOD_CK1_1,668-674,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs199547303,CD2AP,missense,MOD_CK1_1,431-437,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs199547303,CD2AP,missense,MOD_CK1_1,432-438,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs141499220,UNC13D,missense,MOD_CK1_1,294-300,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs183130427,RBM20,missense,MOD_CK1_1,172-178,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs28763971,DSP,missense,MOD_CK1_1,2863-2869,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs28763971,DSP,missense,MOD_CK1_1,2865-2871,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs41272435,CHD7,missense,MOD_CK1_1,100-106,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs190761354,ABCC6,missense,MOD_CK1_1,587-593,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs201745292,CPT2,missense,MOD_CK1_1,391-397,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs34150427,KCNQ1,missense,MOD_CK1_1,644-650,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs183738892,OTUD4,missense,MOD_CK1_1,1004-1010,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs187746691,OTUD4,missense,MOD_CK1_1,42-48,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs145008551,LRP5,missense,MOD_CK1_1,695-701,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs376598131,MFN2,missense,MOD_CK1_1,508-514,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs150062967,LRRK2,missense,MOD_CK1_1,2491-2497,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs201731964,ATP2B3,missense,MOD_CK1_1,582-588,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs545569060,GJB3,missense,MOD_CK1_1,234-240,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs568347441,C10orf2,missense,MOD_CK1_1,493-499,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs138072724,BBS9,missense,MOD_CK1_1,425-431,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs138794842,FZD4,missense,MOD_CK1_1,183-189,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs137853909,MKKS,missense,MOD_CK1_1,335-341,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs187406481,TMPRSS3,missense,MOD_CK1_1,149-155,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs529138303,MYOC,missense,MOD_CK1_1,217-223,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs546367623,DUSP6,missense,MOD_CK1_1,174-180,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs368453319,COL17A1,missense,MOD_CK1_1,1245-1251,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs201388299,F5,missense,MOD_CK1_1,1174-1180,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs191378148,EDA,missense,MOD_CK1_1,335-341,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs4252303,IL10RA,missense,MOD_CK1_1,109-115,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs142790819,SLC3A1,missense,MOD_CK1_1,420-426,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs552694552,KRT5,missense,MOD_CK1_1,571-577,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs548262562,KRT14,missense,MOD_CK1_1,29-35,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs146273185,DFNB31,missense,MOD_CK1_1,217-223,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs143309797,C10orf2,missense,MOD_CK1_1,366-372,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs199473303,SCN5A,missense,MOD_CK1_1,1735-1741,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs371080525,MITF,missense,MOD_CK1_1,101-107,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs373519764,MYO6,missense,MOD_CK1_1,389-395,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs148526538,KRT5,missense,MOD_CK1_1,5-11,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs148526538,KRT5,missense,MOD_CK1_1,8-14,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs201378037,FOXI1,missense,MOD_CK1_1,309-315,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs186298636,RNF216,missense,MOD_CK1_1,109-115,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs192378817,MYO7A,missense,MOD_CK1_1,1120-1126,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs541165691,LRP5,missense,MOD_CK1_1,695-701,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs41308954,KCNH2,missense,MOD_CK1_1,179-185,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs201090454,FOXI1,missense,MOD_CK1_1,363-369,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs375201461,IL10RA,missense,MOD_CK1_1,560-566,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs138018628,PINK1,missense,MOD_CK1_1,225-231,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs200203992,FGA,missense,MOD_CK1_1,297-303,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs76593842,DFNB31,missense,MOD_CK1_1,217-223,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs61735473,PCDH15,missense,MOD_CK1_1,450-456,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs115148599,F5,missense,MOD_CK1_1,1434-1440,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs139445116,COL17A1,missense,MOD_CK1_1,252-258,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs557302067,MYO7A,missense,MOD_CK1_1,351-357,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs115759032,LAMA1,missense,MOD_CK1_1,1931-1937,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs143908409,OTUD4,missense,MOD_CK1_1,480-486,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs146444716,CD2AP,missense,MOD_GSK3_1,553-560,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs146444716,CD2AP,missense,MOD_GSK3_1,558-565,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200762526,F5,missense,MOD_GSK3_1,1364-1371,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs41313697,SCN5A,missense,MOD_GSK3_1,457-464,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs561008244,TYR,missense,MOD_GSK3_1,469-476,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs549070573,BBS2,missense,MOD_GSK3_1,490-497,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs572315698,IL17RD,missense,MOD_GSK3_1,92-99,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs555466415,MYO7A,missense,MOD_GSK3_1,1271-1278,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs183518211,BMPR2,missense,MOD_GSK3_1,568-575,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs183518211,BMPR2,missense,MOD_GSK3_1,571-578,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs537956139,PYGM,missense,MOD_GSK3_1,369-376,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs144672024,LAMA1,missense,MOD_GSK3_1,2614-2621,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs576816351,COL17A1,missense,MOD_GSK3_1,1276-1283,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs576816351,COL17A1,missense,MOD_GSK3_1,1280-1287,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200770952,BBS7,missense,MOD_GSK3_1,283-290,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200433530,JUP,missense,MOD_GSK3_1,377-384,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs149692121,LAMA1,missense,MOD_GSK3_1,506-513,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs184636161,KCNQ1,missense,MOD_GSK3_1,461-468,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs143119752,IL17RD,missense,MOD_GSK3_1,664-671,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs143119752,IL17RD,missense,MOD_GSK3_1,665-672,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs143119752,IL17RD,missense,MOD_GSK3_1,668-675,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs554806195,ABCC6,missense,MOD_GSK3_1,1127-1134,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs150140303,IL10RA,missense,MOD_GSK3_1,21-28,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs199547303,CD2AP,missense,MOD_GSK3_1,428-435,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs199547303,CD2AP,missense,MOD_GSK3_1,432-439,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs138329459,DSP,missense,MOD_GSK3_1,2818-2825,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs41272435,CHD7,missense,MOD_GSK3_1,100-107,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs78151989,LAMA1,missense,MOD_GSK3_1,137-144,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs558831155,HMBS,missense,MOD_GSK3_1,281-288,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs540014314,RBM20,missense,MOD_GSK3_1,1015-1022,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs142885240,DSP,missense,MOD_GSK3_1,1736-1743,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201745292,CPT2,missense,MOD_GSK3_1,391-398,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201174472,NEUROD1,missense,MOD_GSK3_1,206-213,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201026048,PCDH15,missense,MOD_GSK3_1,148-155,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs543699099,KRT5,missense,MOD_GSK3_1,544-551,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs113806080,PYGM,missense,MOD_GSK3_1,665-672,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs533282672,CPT2,missense,MOD_GSK3_1,19-26,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs531924876,COL17A1,missense,MOD_GSK3_1,262-269,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201541597,NPHS1,missense,MOD_GSK3_1,994-1001,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs541584830,PDX1,missense,MOD_GSK3_1,265-272,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs556526711,KRT14,missense,MOD_GSK3_1,25-32,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs527839219,BBS4,missense,MOD_GSK3_1,442-449,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs139420743,FOXI1,missense,MOD_GSK3_1,253-260,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs146408488,F5,missense,MOD_GSK3_1,1070-1077,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs535296791,PRF1,missense,MOD_GSK3_1,143-150,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs570622601,MKKS,missense,MOD_GSK3_1,153-160,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs143567248,DUSP6,missense,MOD_GSK3_1,187-194,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs199473030,KCNH2,missense,MOD_GSK3_1,1095-1102,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs564318120,KISS1R,missense,MOD_GSK3_1,167-174,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs576465085,BAAT,missense,MOD_GSK3_1,28-35,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs145733679,SCN5A,missense,MOD_GSK3_1,509-516,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs568347441,C10orf2,missense,MOD_GSK3_1,493-500,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201860939,BBS2,missense,MOD_GSK3_1,57-64,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs572277602,SLC3A1,missense,MOD_GSK3_1,3-10,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs370143312,JUP,missense,MOD_GSK3_1,189-196,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs535221986,RBM20,missense,MOD_GSK3_1,747-754,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200428510,BMPR2,missense,MOD_GSK3_1,620-627,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200428510,BMPR2,missense,MOD_GSK3_1,621-628,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs369539923,MYO7A,missense,MOD_GSK3_1,1009-1016,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs369539923,MYO7A,missense,MOD_GSK3_1,1011-1018,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs560126604,UNC13D,missense,MOD_GSK3_1,170-177,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs187406481,TMPRSS3,missense,MOD_GSK3_1,146-153,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs17154353,SLC26A4,missense,MOD_GSK3_1,738-745,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs555255264,NPHS1,missense,MOD_GSK3_1,1179-1186,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs182293857,SCN5A,missense,MOD_GSK3_1,1383-1390,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs548754771,DSP,missense,MOD_GSK3_1,2822-2829,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs548754771,DSP,missense,MOD_GSK3_1,2824-2831,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs548754771,DSP,missense,MOD_GSK3_1,2826-2833,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs121912697,SLC3A1,missense,MOD_GSK3_1,360-367,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs546367623,DUSP6,missense,MOD_GSK3_1,175-182,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs368453319,COL17A1,missense,MOD_GSK3_1,1245-1252,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs368453319,COL17A1,missense,MOD_GSK3_1,1249-1256,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs533600930,CHD7,missense,MOD_GSK3_1,2824-2831,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs533600930,CHD7,missense,MOD_GSK3_1,2825-2832,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs192129249,CHD7,missense,MOD_GSK3_1,2525-2532,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs4252303,IL10RA,missense,MOD_GSK3_1,109-116,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs564138835,TYR,missense,MOD_GSK3_1,452-459,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs140018525,F5,missense,MOD_GSK3_1,1274-1281,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs114734812,KRT5,missense,MOD_GSK3_1,544-551,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs542835031,KCNE2,missense,MOD_GSK3_1,67-74,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs9282834,RET,missense,MOD_GSK3_1,485-492,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs551068385,SCN1A,missense,MOD_GSK3_1,210-217,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200996196,LAMA1,missense,MOD_GSK3_1,2815-2822,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200250096,DSP,missense,MOD_GSK3_1,56-63,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs535036148,BBS12,missense,MOD_GSK3_1,685-692,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs567623265,COL17A1,missense,MOD_GSK3_1,1059-1066,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs567623265,COL17A1,missense,MOD_GSK3_1,1063-1070,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs199946321,LAMB3,missense,MOD_GSK3_1,872-879,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs546272425,LMNA,missense,MOD_GSK3_1,300-307,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201920792,F5,missense,MOD_GSK3_1,2151-2158,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs180723721,BBS12,missense,MOD_GSK3_1,107-114,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs547665147,CEP290,missense,MOD_GSK3_1,199-206,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200157005,F5,missense,MOD_GSK3_1,1662-1669,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201067849,BMPR2,missense,MOD_GSK3_1,343-350,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs371080525,MITF,missense,MOD_GSK3_1,101-108,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs373626588,BBS10,missense,MOD_GSK3_1,565-572,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs547915978,F5,missense,MOD_GSK3_1,772-779,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs553523967,BMPR2,missense,MOD_GSK3_1,352-359,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs183015712,BBS9,missense,MOD_GSK3_1,586-593,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs139408369,HMBS,missense,MOD_GSK3_1,281-288,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs549168948,BBS4,missense,MOD_GSK3_1,446-453,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs549168948,BBS4,missense,MOD_GSK3_1,450-457,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs528175399,BBS12,missense,MOD_GSK3_1,107-114,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201378037,FOXI1,missense,MOD_GSK3_1,309-316,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201804583,PRF1,missense,MOD_GSK3_1,133-140,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs146685108,STXBP2,missense,MOD_GSK3_1,466-473,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs192378817,MYO7A,missense,MOD_GSK3_1,1120-1127,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200960909,TYR,missense,MOD_GSK3_1,37-44,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs41308954,KCNH2,missense,MOD_GSK3_1,175-182,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201090454,FOXI1,missense,MOD_GSK3_1,360-367,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs61753180,TYR,missense,MOD_GSK3_1,47-54,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs143264522,UNC13D,missense,MOD_GSK3_1,755-762,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs375201461,IL10RA,missense,MOD_GSK3_1,560-567,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs138018628,PINK1,missense,MOD_GSK3_1,222-229,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs555738896,STX11,missense,MOD_GSK3_1,249-256,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs536728645,SGCB,missense,MOD_GSK3_1,179-186,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200203992,FGA,missense,MOD_GSK3_1,297-304,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs576666901,IL10RA,missense,MOD_GSK3_1,279-286,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201183342,FGA,missense,MOD_GSK3_1,267-274,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201183342,FGA,missense,MOD_GSK3_1,272-279,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs114904237,TMPRSS3,missense,MOD_GSK3_1,432-439,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs61735473,PCDH15,missense,MOD_GSK3_1,450-457,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs542258150,PINK1,missense,MOD_GSK3_1,492-499,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs536614946,F5,missense,MOD_GSK3_1,759-766,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs145966037,RET,missense,MOD_GSK3_1,454-461,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs563952288,PCDH15,missense,MOD_GSK3_1,575-582,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs527378833,CHD7,missense,MOD_GSK3_1,46-53,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs115148599,F5,missense,MOD_GSK3_1,1436-1443,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs563762318,RBM20,missense,MOD_GSK3_1,1176-1183,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs115759032,LAMA1,missense,MOD_GSK3_1,1927-1934,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs539390533,LAMB3,missense,MOD_GSK3_1,920-927,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs146444716,CD2AP,missense,MOD_N-GLC_1,558-563,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs183729115,RET,missense,MOD_N-GLC_1,393-398,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs148708451,KCNA5,missense,MOD_N-GLC_1,298-303,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs180861646,LRRK2,missense,MOD_N-GLC_1,719-724,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs544908256,KCNA5,missense,MOD_N-GLC_1,298-303,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs143997842,LAMA1,missense,MOD_N-GLC_1,554-559,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs200433530,JUP,missense,MOD_N-GLC_1,377-382,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs138329459,DSP,missense,MOD_N-GLC_1,2817-2822,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs561685616,LAMA1,missense,MOD_N-GLC_1,925-930,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs536095313,ABCC6,missense,MOD_N-GLC_1,703-708,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs143433231,LRP5,missense,MOD_N-GLC_1,92-97,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs182293857,SCN5A,missense,MOD_N-GLC_1,1387-1392,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs200570629,SLC3A1,missense,MOD_N-GLC_1,512-517,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs530687764,NEK1,missense,MOD_N-GLC_1,181-186,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs149611371,LAMA1,missense,MOD_N-GLC_1,762-767,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs16957538,BBS2,missense,MOD_N-GLC_1,499-504,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs373652923,DFNB31,missense,MOD_N-GLC_1,625-630,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs151148041,RET,missense,MOD_N-GLC_1,447-452,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs533600930,CHD7,missense,MOD_N-GLC_1,2825-2830,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs4252303,IL10RA,missense,MOD_N-GLC_1,109-114,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs147835286,PCDH15,missense,MOD_N-GLC_1,1174-1179,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs576554728,SLC3A1,missense,MOD_N-GLC_1,213-218,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs575091797,LAMA1,missense,MOD_N-GLC_1,762-767,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs200033170,UNC13D,missense,MOD_N-GLC_1,196-201,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs201768061,F5,missense,MOD_N-GLC_1,976-981,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs551068385,SCN1A,missense,MOD_N-GLC_1,210-215,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs202159230,PDX1,missense,MOD_N-GLC_1,183-188,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs121918166,OCA2,missense,MOD_N-GLC_1,441-446,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs199795359,DSP,missense,MOD_N-GLC_1,1214-1219,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs181378432,DSP,missense,MOD_N-GLC_1,2264-2269,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs532035027,LRP5,missense,MOD_N-GLC_1,704-709,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs547059523,BBS2,missense,MOD_N-GLC_1,392-397,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs199629447,F5,missense,MOD_N-GLC_1,2208-2213,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs199473303,SCN5A,missense,MOD_N-GLC_1,1735-1740,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs373626588,BBS10,missense,MOD_N-GLC_1,565-570,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs201090454,FOXI1,missense,MOD_N-GLC_1,364-369,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs138018628,PINK1,missense,MOD_N-GLC_1,222-227,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs138479596,CPOX,missense,MOD_N-GLC_1,212-217,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs144476761,IL10RA,missense,MOD_N-GLC_1,153-158,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs536614946,F5,missense,MOD_N-GLC_1,759-764,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs55774500,PARK2,missense,MOD_N-GLC_1,80-85,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs202197761,SCN5A,missense,MOD_N-GLC_1,1364-1369,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs181787663,LMBRD1,missense,MOD_N-GLC_1,346-351,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs9332605,F5,missense,MOD_N-GLC_1,976-981,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs201194028,BBS10,missense,MOD_N-GLC_1,121-126,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs535041963,OTUD4,missense,MOD_PLK,1004-1010,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs183518211,BMPR2,missense,MOD_PLK,568-574,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs532783162,IL10RA,missense,MOD_PLK,344-350,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs555763808,OTUD4,missense,MOD_PLK,209-215,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs575447822,CPT2,missense,MOD_PLK,406-412,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs139829321,BAAT,missense,MOD_PLK,327-333,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs184636161,KCNQ1,missense,MOD_PLK,461-467,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs143119752,IL17RD,missense,MOD_PLK,665-671,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs78151989,LAMA1,missense,MOD_PLK,137-143,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs562912411,CCDC28B,missense,MOD_PLK,112-118,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs183738892,OTUD4,missense,MOD_PLK,1004-1010,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs571621861,CEP290,missense,MOD_PLK,423-429,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs80358317,LRP5,missense,MOD_PLK,1119-1125,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs144892179,MKKS,missense,MOD_PLK,366-372,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs150073296,FGA,missense,MOD_PLK,758-764,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs552776932,IL10RA,missense,MOD_PLK,344-350,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs575660501,POLG,missense,MOD_PLK,775-781,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs200262654,LMNA,missense,MOD_PLK,460-466,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs146396982,KCNJ10,missense,MOD_PLK,343-349,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs528729376,BAAT,missense,MOD_PLK,327-333,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs557951406,PRF1,missense,MOD_PLK,81-87,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs148425972,SLC26A4,missense,MOD_PLK,375-381,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs141796804,LRP5,missense,MOD_PLK,692-698,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs572512491,MYOC,missense,MOD_PLK,445-451,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs541165691,LRP5,missense,MOD_PLK,692-698,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs41308954,KCNH2,missense,MOD_PLK,176-182,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs189633442,OCA2,missense,MOD_PLK,705-711,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs137853074,KCNJ10,missense,MOD_PLK,343-349,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs140406696,PRPH2,missense,MOD_PLK,275-281,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs9332604,F5,missense,MOD_PLK,963-969,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs115759032,LAMA1,missense,MOD_PLK,1928-1934,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs143796440,CHD7,missense,DOC_MAPK_gen_1,2023-2030,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs372077201,CHD7,missense,DOC_MAPK_gen_1,2023-2030,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs11551760,KRT14,missense,DOC_MAPK_gen_1,446-455,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs148604293,BBS12,missense,DOC_MAPK_gen_1,261-271,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs372585344,NEK1,missense,DOC_MAPK_gen_1,375-384,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs372585344,NEK1,missense,DOC_MAPK_gen_1,376-384,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs561265847,LMBRD1,missense,DOC_MAPK_gen_1,404-413,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs540065111,STX11,missense,DOC_MAPK_gen_1,210-217,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs569221128,RAB27A,missense,DOC_MAPK_gen_1,141-151,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs541139673,MYO7A,missense,DOC_MAPK_gen_1,811-820,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs61754402,PRPH2,missense,DOC_MAPK_gen_1,11-22,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs61754402,PRPH2,missense,DOC_MAPK_gen_1,12-22,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs61754402,PRPH2,missense,DOC_MAPK_gen_1,13-22,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs555529285,DSP,missense,DOC_MAPK_gen_1,866-876,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs533618528,NOD2,missense,DOC_MAPK_gen_1,756-764,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs59588658,ABCC6,missense,DOC_MAPK_gen_1,1418-1425,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs562257866,SLC3A1,missense,DOC_MAPK_gen_1,81-90,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs200889495,HMBS,missense,DOC_MAPK_gen_1,345-353,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs2229275,MTR,missense,DOC_MAPK_gen_1,486-497,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs2229275,MTR,missense,DOC_MAPK_gen_1,487-497,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs2229275,MTR,missense,DOC_MAPK_gen_1,489-497,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs532361142,BBS2,missense,DOC_MAPK_gen_1,638-647,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs199795359,DSP,missense,DOC_MAPK_gen_1,1207-1216,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs559720365,TYR,missense,DOC_MAPK_gen_1,131-140,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs528755232,CDH23,missense,DOC_MAPK_gen_1,546-554,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs546115565,SLC26A4,missense,DOC_MAPK_gen_1,473-483,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs577589879,PYGM,missense,DOC_MAPK_gen_1,793-803,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs557510313,ALAD,missense,DOC_MAPK_gen_1,308-316,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs201326686,MYH7,missense,DOC_MAPK_gen_1,1557-1565,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs201003237,LAMB3,missense,DOC_MAPK_gen_1,886-892,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs74315352,PARK7,missense,DOC_MAPK_gen_1,145-153,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs529251704,MYO7A,missense,DOC_MAPK_gen_1,834-843,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs77018758,LRRK2,missense,DOC_MAPK_gen_1,1314-1321,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs575227358,FGFR1,missense,DOC_MAPK_gen_1,504-513,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs45611033,MYH7,missense,DOC_MAPK_gen_1,1042-1048,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs150652021,MTR,missense,DOC_MAPK_gen_1,486-497,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs150652021,MTR,missense,DOC_MAPK_gen_1,487-497,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs150652021,MTR,missense,DOC_MAPK_gen_1,489-497,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs200338012,DSP,missense,DOC_MAPK_gen_1,866-876,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs143796440,CHD7,missense,LIG_SH3_3,2026-2032,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs148708451,KCNA5,missense,LIG_SH3_3,300-306,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs147028059,PARK2,missense,LIG_SH3_3,275-281,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs372077201,CHD7,missense,LIG_SH3_3,2026-2032,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs181206306,COL17A1,missense,LIG_SH3_3,765-771,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs544908256,KCNA5,missense,LIG_SH3_3,300-306,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs561518392,LAMA1,missense,LIG_SH3_3,1396-1402,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201019203,DFNB31,missense,LIG_SH3_3,680-686,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs150140303,IL10RA,missense,LIG_SH3_3,24-30,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201793759,NEK1,missense,LIG_SH3_3,482-488,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201174472,NEUROD1,missense,LIG_SH3_3,202-208,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs533282672,CPT2,missense,LIG_SH3_3,15-21,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs533282672,CPT2,missense,LIG_SH3_3,18-24,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201831535,SCN5A,missense,LIG_SH3_3,1036-1042,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs1127291,LRP5,missense,LIG_SH3_3,1524-1530,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs117564807,COL17A1,missense,LIG_SH3_3,919-925,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs377139558,RBM20,missense,LIG_SH3_3,184-190,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs555879351,SCN5A,missense,LIG_SH3_3,986-992,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs180700967,RET,missense,LIG_SH3_3,1064-1070,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs199473030,KCNH2,missense,LIG_SH3_3,1093-1099,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs550442340,KISS1R,missense,LIG_SH3_3,353-359,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201076024,NOD2,missense,LIG_SH3_3,721-727,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201873722,NEUROD1,missense,LIG_SH3_3,212-218,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs549370363,FOXC1,missense,LIG_SH3_3,199-205,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs549370363,FOXC1,missense,LIG_SH3_3,200-206,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs536357058,RBM20,missense,LIG_SH3_3,78-84,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs573639672,COL17A1,missense,LIG_SH3_3,702-708,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs199810018,PARK2,missense,LIG_SH3_3,183-189,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs573426783,RBM20,missense,LIG_SH3_3,10-16,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs180941579,LRP5,missense,LIG_SH3_3,664-670,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs191342808,RBM20,missense,LIG_SH3_3,73-79,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs551155761,DFNB31,missense,LIG_SH3_3,580-586,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs140018525,F5,missense,LIG_SH3_3,1272-1278,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs117506164,CHD7,missense,LIG_SH3_3,942-948,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs538359973,F5,missense,LIG_SH3_3,1317-1323,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs571794057,UNC13D,missense,LIG_SH3_3,141-147,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs563657853,LRP5,missense,LIG_SH3_3,1428-1434,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs559937676,POLG,missense,LIG_SH3_3,564-570,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs56264519,TMPRSS3,missense,LIG_SH3_3,425-431,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs73329731,COL17A1,missense,LIG_SH3_3,787-793,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201968813,RNF216,missense,LIG_SH3_3,865-871,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs375201461,IL10RA,missense,LIG_SH3_3,563-569,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs567482511,PYGM,missense,LIG_SH3_3,43-49,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs556988678,LRRK2,missense,LIG_SH3_3,1616-1622,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs149513065,RET,missense,LIG_SH3_3,1064-1070,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs545525268,COL17A1,missense,LIG_SH3_3,1176-1182,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs545525268,COL17A1,missense,LIG_SH3_3,1177-1183,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs545525268,COL17A1,missense,LIG_SH3_3,1179-1185,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs545525268,COL17A1,missense,LIG_SH3_3,1180-1186,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201457738,RNF216,missense,LIG_SH3_3,859-865,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs148751644,LAMA1,missense,LIG_SH3_3,390-396,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs201707482,DFNB31,missense,LIG_SH3_3,643-649,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs189196778,LAMB3,missense,LIG_SH3_3,388-394,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs529695988,OCA2,missense,LIG_SH3_3,112-118,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs138767834,DFNB31,missense,LIG_SH3_3,723-729,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs531422315,POLG,missense,LIG_SH3_3,184-190,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs572609043,DFNB31,missense,LIG_SH3_3,653-659,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs5743278,NOD2,missense,LIG_SH3_3,721-727,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs200762526,F5,missense,LIG_FHA_1,1363-1369,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs144672024,LAMA1,missense,LIG_FHA_1,2615-2621,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs55661958,UNC13D,missense,LIG_FHA_1,297-303,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs12720457,KCNQ1,missense,LIG_FHA_1,389-395,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs575447822,CPT2,missense,LIG_FHA_1,407-413,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs200093674,SLC3A1,missense,LIG_FHA_1,102-108,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs117836686,NOD2,missense,LIG_FHA_1,243-249,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs141802660,F5,missense,LIG_FHA_1,1401-1407,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs557172581,BMPR2,missense,LIG_FHA_1,557-563,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs200720761,BBS7,missense,LIG_FHA_1,478-484,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs529018971,RET,missense,LIG_FHA_1,46-52,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs141499220,UNC13D,missense,LIG_FHA_1,297-303,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs201745292,CPT2,missense,LIG_FHA_1,392-398,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs150587582,BBS10,missense,LIG_FHA_1,292-298,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs200103404,NPHS2,missense,LIG_FHA_1,230-236,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs201541597,NPHS1,missense,LIG_FHA_1,995-1001,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs568608275,GGCX,missense,LIG_FHA_1,418-424,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs571621861,CEP290,missense,LIG_FHA_1,424-430,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs192540254,CEP290,missense,LIG_FHA_1,2455-2461,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs139853866,OCA2,missense,LIG_FHA_1,451-457,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs149233226,SLC45A2,missense,LIG_FHA_1,501-507,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs17466213,LRRK2,missense,LIG_FHA_1,1366-1372,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs536095313,ABCC6,missense,LIG_FHA_1,703-709,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs192018835,MYO7A,missense,LIG_FHA_1,1968-1974,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs116617171,NPHS1,missense,LIG_FHA_1,16-22,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs36225458,OTUD4,missense,LIG_FHA_1,123-129,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs142948132,EDA,missense,LIG_FHA_1,331-337,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs2234927,MYOC,missense,LIG_FHA_1,202-208,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs116898670,ABCC6,missense,LIG_FHA_1,803-809,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs145733679,SCN5A,missense,LIG_FHA_1,510-516,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs59588658,ABCC6,missense,LIG_FHA_1,1418-1424,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs150296134,CEP290,missense,LIG_FHA_1,108-114,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs190487176,C10orf2,missense,LIG_FHA_1,643-649,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs560126604,UNC13D,missense,LIG_FHA_1,171-177,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs200949139,PINK1,missense,LIG_FHA_1,311-317,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs148732080,TACR3,missense,LIG_FHA_1,244-250,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs149611371,LAMA1,missense,LIG_FHA_1,762-768,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs201779301,LRP5,missense,LIG_FHA_1,435-441,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs151148041,RET,missense,LIG_FHA_1,449-455,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs191378148,EDA,missense,LIG_FHA_1,331-337,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs557063658,HAMP,missense,LIG_FHA_1,29-35,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs202039659,HNF1A,missense,LIG_FHA_1,513-519,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs575091797,LAMA1,missense,LIG_FHA_1,762-768,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs200827959,MYO6,missense,LIG_FHA_1,589-595,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs200139879,SLC26A4,missense,LIG_FHA_1,92-98,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs199473054,SCN5A,missense,LIG_FHA_1,90-96,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs117506164,CHD7,missense,LIG_FHA_1,940-946,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs121918166,OCA2,missense,LIG_FHA_1,442-448,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs121918166,OCA2,missense,LIG_FHA_1,443-449,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs140882212,BBS9,missense,LIG_FHA_1,761-767,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs556930184,UNC13D,missense,LIG_FHA_1,457-463,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs566907093,KCNQ1,missense,LIG_FHA_1,263-269,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs199553497,MKKS,missense,LIG_FHA_1,17-23,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs74315339,MYOC,missense,LIG_FHA_1,48-54,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs528755232,CDH23,missense,LIG_FHA_1,542-548,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs563657853,LRP5,missense,LIG_FHA_1,1428-1434,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs576796649,UNC13D,missense,LIG_FHA_1,449-455,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs577589879,PYGM,missense,LIG_FHA_1,797-803,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs201067849,BMPR2,missense,LIG_FHA_1,344-350,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs373519764,MYO6,missense,LIG_FHA_1,389-395,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs149338478,NOD2,missense,LIG_FHA_1,292-298,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs532542968,MYO7A,missense,LIG_FHA_1,1997-2003,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs146391864,MYOC,missense,LIG_FHA_1,323-329,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs201804583,PRF1,missense,LIG_FHA_1,138-144,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs74034411,POLG,missense,LIG_FHA_1,1092-1098,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs201003237,LAMB3,missense,LIG_FHA_1,886-892,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs192378817,MYO7A,missense,LIG_FHA_1,1121-1127,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs558502886,KCNJ10,missense,LIG_FHA_1,212-218,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs201090454,FOXI1,missense,LIG_FHA_1,364-370,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs375201461,IL10RA,missense,LIG_FHA_1,565-571,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs186283932,FGA,missense,LIG_FHA_1,80-86,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs554736651,PROKR2,missense,LIG_FHA_1,191-197,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs542793145,C10orf2,missense,LIG_FHA_1,643-649,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs542296728,PRPH2,missense,LIG_FHA_1,238-244,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs542144750,JUP,missense,LIG_FHA_1,60-66,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs572126852,PROKR2,missense,LIG_FHA_1,191-197,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs114904237,TMPRSS3,missense,LIG_FHA_1,436-442,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs546883829,POLG,missense,LIG_FHA_1,987-993,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs117225191,LAMA1,missense,LIG_FHA_1,2139-2145,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs117225191,LAMA1,missense,LIG_FHA_1,2141-2147,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs536614946,F5,missense,LIG_FHA_1,760-766,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs140234450,CCDC28B,missense,LIG_FHA_1,151-157,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs577519439,LRP5,missense,LIG_FHA_1,1045-1051,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs145966037,RET,missense,LIG_FHA_1,449-455,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs563952288,PCDH15,missense,LIG_FHA_1,576-582,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs140406696,PRPH2,missense,LIG_FHA_1,276-282,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs142863601,BBS10,missense,LIG_FHA_1,136-142,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs550894458,HNF1A,missense,LIG_FHA_1,134-140,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs34010619,OCA2,missense,LIG_FHA_1,333-339,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs115759032,LAMA1,missense,LIG_FHA_1,1928-1934,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs538188579,TTC8,missense,LIG_FHA_1,499-505,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs200762526,F5,missense,LIG_SUMO_SIM_par_1,1364-1369,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs146288080,PARK2,missense,LIG_SUMO_SIM_par_1,13-22,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs142293185,MYO7A,missense,LIG_SUMO_SIM_par_1,1951-1958,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs142293185,MYO7A,missense,LIG_SUMO_SIM_par_1,1952-1958,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs142648132,MTR,missense,LIG_SUMO_SIM_par_1,244-249,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs376598131,MFN2,missense,LIG_SUMO_SIM_par_1,505-511,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs149233226,SLC45A2,missense,LIG_SUMO_SIM_par_1,503-510,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs149233226,SLC45A2,missense,LIG_SUMO_SIM_par_1,504-510,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs36225458,OTUD4,missense,LIG_SUMO_SIM_par_1,124-132,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs555531536,RNF216,missense,LIG_SUMO_SIM_par_1,177-183,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs143175221,HFE,missense,LIG_SUMO_SIM_par_1,292-298,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs551593576,LRRK2,missense,LIG_SUMO_SIM_par_1,578-583,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs376289528,JUP,missense,LIG_SUMO_SIM_par_1,153-160,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs75813654,KCNQ1,missense,LIG_SUMO_SIM_par_1,202-209,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs75813654,KCNQ1,missense,LIG_SUMO_SIM_par_1,203-209,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs180723721,BBS12,missense,LIG_SUMO_SIM_par_1,110-118,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs180723721,BBS12,missense,LIG_SUMO_SIM_par_1,111-118,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs528175399,BBS12,missense,LIG_SUMO_SIM_par_1,110-118,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs528175399,BBS12,missense,LIG_SUMO_SIM_par_1,111-118,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs531422315,POLG,missense,LIG_SUMO_SIM_par_1,185-192,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs200762526,F5,missense,MOD_NEK2_1,1368-1373,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs563490827,CHD7,missense,MOD_NEK2_1,455-460,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs397517880,USH1C,missense,MOD_NEK2_1,98-103,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs183729115,RET,missense,MOD_NEK2_1,393-398,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs555466415,MYO7A,missense,MOD_NEK2_1,1273-1278,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs111033527,SLC26A4,missense,MOD_NEK2_1,407-412,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs201926546,RNF216,missense,MOD_NEK2_1,118-123,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs199810842,C10orf2,missense,MOD_NEK2_1,175-180,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs144672024,LAMA1,missense,MOD_NEK2_1,2612-2617,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs200770952,BBS7,missense,MOD_NEK2_1,285-290,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs138877178,F5,missense,MOD_NEK2_1,1811-1816,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs554806195,ABCC6,missense,MOD_NEK2_1,1127-1132,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs28763971,DSP,missense,MOD_NEK2_1,2864-2869,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs189625169,GGCX,missense,MOD_NEK2_1,272-277,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs557790670,CCDC28B,missense,MOD_NEK2_1,179-184,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs142648132,MTR,missense,MOD_NEK2_1,244-249,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs150587582,BBS10,missense,MOD_NEK2_1,291-296,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs114615449,NPHS1,missense,MOD_NEK2_1,599-604,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs372685495,BBS7,missense,MOD_NEK2_1,441-446,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs185645212,POLG,missense,MOD_NEK2_1,717-722,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs570622601,MKKS,missense,MOD_NEK2_1,153-158,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs147952620,SLC26A4,missense,MOD_NEK2_1,407-412,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs551542832,PINK1,missense,MOD_NEK2_1,19-24,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs542347980,F5,missense,MOD_NEK2_1,1811-1816,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs142948132,EDA,missense,MOD_NEK2_1,330-335,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs116898670,ABCC6,missense,MOD_NEK2_1,802-807,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs561738497,KRT5,missense,MOD_NEK2_1,368-373,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs561540830,LMBRD1,missense,MOD_NEK2_1,377-382,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs111033284,MYO7A,missense,MOD_NEK2_1,237-242,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs145733679,SCN5A,missense,MOD_NEK2_1,509-514,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs59588658,ABCC6,missense,MOD_NEK2_1,1417-1422,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs199954814,BMPR2,missense,MOD_NEK2_1,304-309,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs369539923,MYO7A,missense,MOD_NEK2_1,1009-1014,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs143433231,LRP5,missense,MOD_NEK2_1,92-97,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs189914613,PDZD7,missense,MOD_NEK2_1,153-158,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs532376208,UNC13D,missense,MOD_NEK2_1,347-352,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs548074036,CHD7,missense,MOD_NEK2_1,455-460,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs2228980,SCN2A,missense,MOD_NEK2_1,903-908,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs191342808,RBM20,missense,MOD_NEK2_1,74-79,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs192129249,CHD7,missense,MOD_NEK2_1,2525-2530,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs529182720,SLC26A4,missense,MOD_NEK2_1,96-101,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs34620165,BBS4,missense,MOD_NEK2_1,245-250,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs542110883,MYO7A,missense,MOD_NEK2_1,800-805,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs137900287,KAL1,missense,MOD_NEK2_1,585-590,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs542835031,KCNE2,missense,MOD_NEK2_1,68-73,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs200139879,SLC26A4,missense,MOD_NEK2_1,96-101,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs566907093,KCNQ1,missense,MOD_NEK2_1,262-267,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs545636414,LRP5,missense,MOD_NEK2_1,827-832,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs17857451,BBS12,missense,MOD_NEK2_1,613-618,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs532035027,LRP5,missense,MOD_NEK2_1,704-709,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs373626588,BBS10,missense,MOD_NEK2_1,562-567,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs562616743,LRP5,missense,MOD_NEK2_1,1158-1163,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs553523967,BMPR2,missense,MOD_NEK2_1,356-361,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs532542968,MYO7A,missense,MOD_NEK2_1,1997-2002,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs146477715,DFNB31,missense,MOD_NEK2_1,290-295,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs10255104,BBS9,missense,MOD_NEK2_1,131-136,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs74034411,POLG,missense,MOD_NEK2_1,1092-1097,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs59260335,LAMB3,missense,MOD_NEK2_1,846-851,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs558502886,KCNJ10,missense,MOD_NEK2_1,217-222,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs201090454,FOXI1,missense,MOD_NEK2_1,360-365,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs145774832,LRP5,missense,MOD_NEK2_1,1081-1086,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs117737169,MKKS,missense,MOD_NEK2_1,327-332,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs61735473,PCDH15,missense,MOD_NEK2_1,452-457,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs78387970,RNF216,missense,MOD_NEK2_1,212-217,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs144112103,BBS9,missense,MOD_NEK2_1,636-641,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs536614946,F5,missense,MOD_NEK2_1,764-769,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs55774500,PARK2,missense,MOD_NEK2_1,80-85,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs201030241,LRP5,missense,MOD_NEK2_1,1515-1520,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs201030241,LRP5,missense,MOD_NEK2_1,1516-1521,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs554554993,LMBRD1,missense,MOD_NEK2_1,184-189,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs140406696,PRPH2,missense,MOD_NEK2_1,275-280,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs148824832,FGA,missense,MOD_NEK2_1,783-788,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs147371999,CEP290,missense,MOD_NEK2_1,520-525,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs77811721,LAMA1,missense,MOD_NEK2_1,141-146,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs200762526,F5,missense,MOD_PIKK_1,1368-1374,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs139571975,NOD2,missense,MOD_PIKK_1,160-166,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs201690512,OTUD4,missense,MOD_PIKK_1,563-569,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs183130427,RBM20,missense,MOD_PIKK_1,172-178,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs535205981,MYO7A,missense,MOD_PIKK_1,292-298,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs200664061,SLC26A4,missense,MOD_PIKK_1,732-738,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs41272435,CHD7,missense,MOD_PIKK_1,100-106,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs145125791,NPHS1,missense,MOD_PIKK_1,188-194,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs200788482,POLG,missense,MOD_PIKK_1,1232-1238,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs10027479,BBS12,missense,MOD_PIKK_1,455-461,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs532529860,PYGM,missense,MOD_PIKK_1,208-214,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs376598131,MFN2,missense,MOD_PIKK_1,508-514,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs560742342,CHD7,missense,MOD_PIKK_1,208-214,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs561152114,KCNA5,missense,MOD_PIKK_1,538-544,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs561152114,KCNA5,missense,MOD_PIKK_1,540-546,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs571978685,OTUD4,missense,MOD_PIKK_1,897-903,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs59588658,ABCC6,missense,MOD_PIKK_1,1417-1423,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs138072724,BBS9,missense,MOD_PIKK_1,422-428,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs572351621,ABCC6,missense,MOD_PIKK_1,1139-1145,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs537628821,HNF1A,missense,MOD_PIKK_1,246-252,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs560126604,UNC13D,missense,MOD_PIKK_1,170-176,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs142327258,MKKS,missense,MOD_PIKK_1,492-498,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs35222922,NEK1,missense,MOD_PIKK_1,282-288,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs533600930,CHD7,missense,MOD_PIKK_1,2829-2835,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs144738019,OTUD4,missense,MOD_PIKK_1,897-903,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs559222331,MITF,missense,MOD_PIKK_1,90-96,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs140882212,BBS9,missense,MOD_PIKK_1,760-766,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs150067562,TTC8,missense,MOD_PIKK_1,103-109,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs199946321,LAMB3,missense,MOD_PIKK_1,876-882,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs547059523,BBS2,missense,MOD_PIKK_1,392-398,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs547665147,CEP290,missense,MOD_PIKK_1,203-209,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs41278630,MFN2,missense,MOD_PIKK_1,292-298,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs576666901,IL10RA,missense,MOD_PIKK_1,279-285,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs542144750,JUP,missense,MOD_PIKK_1,65-71,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs117737169,MKKS,missense,MOD_PIKK_1,327-333,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs61735473,PCDH15,missense,MOD_PIKK_1,452-458,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs201988582,CEP290,missense,MOD_PIKK_1,359-365,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs555167928,DSP,missense,MOD_PIKK_1,2673-2679,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs115148599,F5,missense,MOD_PIKK_1,1431-1437,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs144744401,UNC13D,missense,MOD_PIKK_1,965-971,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs139598219,NPHS1,missense,MOD_PIKK_1,188-194,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs538188579,TTC8,missense,MOD_PIKK_1,498-504,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs563490827,CHD7,missense,LIG_BRCT_BRCA1_1,457-461,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs199547303,CD2AP,missense,LIG_BRCT_BRCA1_1,433-437,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs145008551,LRP5,missense,LIG_BRCT_BRCA1_1,699-703,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs199655229,ALAD,missense,LIG_BRCT_BRCA1_1,8-12,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs546558127,FZD4,missense,LIG_BRCT_BRCA1_1,280-284,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs565924265,ABCC6,missense,LIG_BRCT_BRCA1_1,320-324,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs202157354,LRRK2,missense,LIG_BRCT_BRCA1_1,51-55,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs200951928,TYR,missense,LIG_BRCT_BRCA1_1,91-95,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs552694552,KRT5,missense,LIG_BRCT_BRCA1_1,573-577,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs201378037,FOXI1,missense,LIG_BRCT_BRCA1_1,315-319,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs41313697,SCN5A,missense,DOC_WW_Pin1_4,461-466,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs183518211,BMPR2,missense,DOC_WW_Pin1_4,572-577,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs201690512,OTUD4,missense,DOC_WW_Pin1_4,568-573,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs573797955,CPOX,missense,DOC_WW_Pin1_4,281-286,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs529018971,RET,missense,DOC_WW_Pin1_4,45-50,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs150140303,IL10RA,missense,DOC_WW_Pin1_4,25-30,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs569249595,HNF1A,missense,DOC_WW_Pin1_4,349-354,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs201745292,CPT2,missense,DOC_WW_Pin1_4,395-400,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs535392006,FLRT3,missense,DOC_WW_Pin1_4,490-495,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs531924876,COL17A1,missense,DOC_WW_Pin1_4,264-269,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs201831535,SCN5A,missense,DOC_WW_Pin1_4,1035-1040,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs191435594,CHD7,missense,DOC_WW_Pin1_4,389-394,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs140918872,NOD2,missense,DOC_WW_Pin1_4,393-398,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs61340537,ABCC6,missense,DOC_WW_Pin1_4,941-946,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs200313391,MYO7A,missense,DOC_WW_Pin1_4,2070-2075,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs115737075,RNF216,missense,DOC_WW_Pin1_4,45-50,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs199473030,KCNH2,missense,DOC_WW_Pin1_4,1095-1100,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs183443251,MYO7A,missense,DOC_WW_Pin1_4,346-351,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs201860939,BBS2,missense,DOC_WW_Pin1_4,57-62,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs114544692,LAMB3,missense,DOC_WW_Pin1_4,794-799,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs58559150,LRRK2,missense,DOC_WW_Pin1_4,923-928,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs189794855,KCNQ1,missense,DOC_WW_Pin1_4,495-500,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs536357058,RBM20,missense,DOC_WW_Pin1_4,82-87,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs567793250,NOD2,missense,DOC_WW_Pin1_4,20-25,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs551271865,OTUD4,missense,DOC_WW_Pin1_4,489-494,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs373652923,DFNB31,missense,DOC_WW_Pin1_4,625-630,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs140018525,F5,missense,DOC_WW_Pin1_4,1274-1279,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs143456081,CPOX,missense,DOC_WW_Pin1_4,429-434,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs559222331,MITF,missense,DOC_WW_Pin1_4,92-97,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs546997981,NPHS1,missense,DOC_WW_Pin1_4,686-691,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs558693763,LAMA1,missense,DOC_WW_Pin1_4,2230-2235,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs200996196,LAMA1,missense,DOC_WW_Pin1_4,2815-2820,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs188054898,RBM20,missense,DOC_WW_Pin1_4,1057-1062,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs201556325,F5,missense,DOC_WW_Pin1_4,1687-1692,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs534523640,DFNB31,missense,DOC_WW_Pin1_4,682-687,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs201810995,LRRK2,missense,DOC_WW_Pin1_4,923-928,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs563657853,LRP5,missense,DOC_WW_Pin1_4,1427-1432,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs150232968,PYGM,missense,DOC_WW_Pin1_4,226-231,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs147356378,RBM20,missense,DOC_WW_Pin1_4,1084-1089,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs140716236,NOD2,missense,DOC_WW_Pin1_4,393-398,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs201804583,PRF1,missense,DOC_WW_Pin1_4,133-138,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs200960909,TYR,missense,DOC_WW_Pin1_4,41-46,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs576666901,IL10RA,missense,DOC_WW_Pin1_4,283-288,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs115148599,F5,missense,DOC_WW_Pin1_4,1436-1441,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs572609043,DFNB31,missense,DOC_WW_Pin1_4,652-657,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs147680216,WNT10A,missense,DOC_WW_Pin1_4,212-217,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs77811721,LAMA1,missense,DOC_WW_Pin1_4,144-149,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs41313697,SCN5A,missense,LIG_14-3-3_CanoR_1,458-462,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs567975394,TMPRSS3,missense,LIG_14-3-3_CanoR_1,210-218,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs567975394,TMPRSS3,missense,LIG_14-3-3_CanoR_1,211-218,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs145654854,MFN2,missense,LIG_14-3-3_CanoR_1,519-525,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs576380462,NPHS1,missense,LIG_14-3-3_CanoR_1,888-894,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs372505798,MYH7B,missense,LIG_14-3-3_CanoR_1,1247-1255,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs372768607,MYO7A,missense,LIG_14-3-3_CanoR_1,1827-1834,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs545466982,NOD2,missense,LIG_14-3-3_CanoR_1,420-430,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs555797304,KCNH2,missense,LIG_14-3-3_CanoR_1,1069-1074,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs201742672,NPHS1,missense,LIG_14-3-3_CanoR_1,697-706,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs115347245,PYGM,missense,LIG_14-3-3_CanoR_1,622-631,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs200103404,NPHS2,missense,LIG_14-3-3_CanoR_1,229-236,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs562225614,NOD2,missense,LIG_14-3-3_CanoR_1,420-430,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs143994626,DSP,missense,LIG_14-3-3_CanoR_1,315-321,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs201591132,PYGM,missense,LIG_14-3-3_CanoR_1,622-631,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs573548957,KRT5,missense,LIG_14-3-3_CanoR_1,163-172,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs538845625,BMPR2,missense,LIG_14-3-3_CanoR_1,529-538,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs201731964,ATP2B3,missense,LIG_14-3-3_CanoR_1,580-590,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs59588658,ABCC6,missense,LIG_14-3-3_CanoR_1,1418-1425,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs542346752,DFNB31,missense,LIG_14-3-3_CanoR_1,33-42,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs572351621,ABCC6,missense,LIG_14-3-3_CanoR_1,1138-1147,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs137853000,TMPRSS3,missense,LIG_14-3-3_CanoR_1,210-218,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs137853000,TMPRSS3,missense,LIG_14-3-3_CanoR_1,211-218,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs199954814,BMPR2,missense,LIG_14-3-3_CanoR_1,303-309,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs565923862,FGG,missense,LIG_14-3-3_CanoR_1,282-291,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs150880478,TTC8,missense,LIG_14-3-3_CanoR_1,89-95,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs546367623,DUSP6,missense,LIG_14-3-3_CanoR_1,171-180,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs60720877,KRT5,missense,LIG_14-3-3_CanoR_1,163-172,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs559222331,MITF,missense,LIG_14-3-3_CanoR_1,89-98,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs577048598,FZD4,missense,LIG_14-3-3_CanoR_1,466-474,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs35641839,MYO7A,missense,LIG_14-3-3_CanoR_1,675-679,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs548262562,KRT14,missense,LIG_14-3-3_CanoR_1,30-35,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs74315339,MYOC,missense,LIG_14-3-3_CanoR_1,46-52,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs200157005,F5,missense,LIG_14-3-3_CanoR_1,1666-1671,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs145009013,SCN5A,missense,LIG_14-3-3_CanoR_1,1982-1990,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs373519764,MYO6,missense,LIG_14-3-3_CanoR_1,387-396,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs578110162,MKKS,missense,LIG_14-3-3_CanoR_1,31-39,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs183015712,BBS9,missense,LIG_14-3-3_CanoR_1,587-591,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs61736659,PYGM,missense,LIG_14-3-3_CanoR_1,650-654,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs114904237,TMPRSS3,missense,LIG_14-3-3_CanoR_1,436-441,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs566081370,SCN1A,missense,LIG_14-3-3_CanoR_1,1208-1215,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs115759032,LAMA1,missense,LIG_14-3-3_CanoR_1,1925-1933,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs41313697,SCN5A,missense,MOD_CK2_1,456-462,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs59593133,ABCC6,missense,MOD_CK2_1,742-748,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs139571975,NOD2,missense,MOD_CK2_1,160-166,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs113941736,CEP41,missense,MOD_CK2_1,235-241,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs199653619,OTUD4,missense,MOD_CK2_1,159-165,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs199547303,CD2AP,missense,MOD_CK2_1,432-438,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs146957466,BMPR2,missense,MOD_CK2_1,425-431,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs142293185,MYO7A,missense,MOD_CK2_1,1952-1958,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs148225763,LAMA1,missense,MOD_CK2_1,1249-1255,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs142648132,MTR,missense,MOD_CK2_1,246-252,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs532041890,CEP290,missense,MOD_CK2_1,1377-1383,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs200641606,MYO7A,missense,MOD_CK2_1,962-968,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs139420743,FOXI1,missense,MOD_CK2_1,259-265,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs536095313,ABCC6,missense,MOD_CK2_1,703-709,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs201860939,BBS2,missense,MOD_CK2_1,57-63,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs138072724,BBS9,missense,MOD_CK2_1,425-431,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs200428510,BMPR2,missense,MOD_CK2_1,625-631,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs536569775,CHD7,missense,MOD_CK2_1,2639-2645,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs561821477,CHD7,missense,MOD_CK2_1,1440-1446,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs17154353,SLC26A4,missense,MOD_CK2_1,738-744,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs551271865,OTUD4,missense,MOD_CK2_1,489-495,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs114040223,LAMB3,missense,MOD_CK2_1,1038-1044,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs535280618,PCDH15,missense,MOD_CK2_1,537-543,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs16957538,BBS2,missense,MOD_CK2_1,499-505,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs546367623,DUSP6,missense,MOD_CK2_1,175-181,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs573426783,RBM20,missense,MOD_CK2_1,11-17,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs2228980,SCN2A,missense,MOD_CK2_1,903-909,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs565096078,PDZD7,missense,MOD_CK2_1,111-117,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs549481773,F5,missense,MOD_CK2_1,2023-2029,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs533600930,CHD7,missense,MOD_CK2_1,2829-2835,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs201388299,F5,missense,MOD_CK2_1,1174-1180,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs143456081,CPOX,missense,MOD_CK2_1,429-435,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs142790819,SLC3A1,missense,MOD_CK2_1,420-426,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs137900287,KAL1,missense,MOD_CK2_1,585-591,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs546440535,PDZD7,missense,MOD_CK2_1,111-117,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs35641839,MYO7A,missense,MOD_CK2_1,674-680,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs532035027,LRP5,missense,MOD_CK2_1,704-710,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs199946321,LAMB3,missense,MOD_CK2_1,876-882,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs554887705,NOD2,missense,MOD_CK2_1,386-392,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs199988202,HFE,missense,MOD_CK2_1,101-107,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs531250955,MYH7,missense,MOD_CK2_1,1736-1742,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs199720912,NEXN,missense,MOD_CK2_1,77-83,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs61736659,PYGM,missense,MOD_CK2_1,649-655,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs565518624,NEXN,missense,MOD_CK2_1,85-91,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs143264522,UNC13D,missense,MOD_CK2_1,759-765,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs138018628,PINK1,missense,MOD_CK2_1,225-231,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs536728645,SGCB,missense,MOD_CK2_1,179-185,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs201370621,RBM20,missense,MOD_CK2_1,888-894,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs199565370,PYGM,missense,MOD_CK2_1,3-9,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs145966037,RET,missense,MOD_CK2_1,453-459,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs573410951,LAMB3,missense,MOD_CK2_1,905-911,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs61737395,KCNA5,missense,MOD_CK2_1,27-33,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs41313697,SCN5A,missense,MOD_PKA_2,457-463,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs576380462,NPHS1,missense,MOD_PKA_2,887-893,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs9456735,PARK2,missense,MOD_PKA_2,190-196,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs372768607,MYO7A,missense,MOD_PKA_2,1826-1832,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs576809888,USH1C,missense,MOD_PKA_2,195-201,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs553511620,FZD4,missense,MOD_PKA_2,48-54,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs117303816,LAMA1,missense,MOD_PKA_2,1987-1993,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs560742342,CHD7,missense,MOD_PKA_2,208-214,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs551542832,PINK1,missense,MOD_PKA_2,19-25,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs545569060,GJB3,missense,MOD_PKA_2,234-240,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs546558127,FZD4,missense,MOD_PKA_2,278-284,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs202157354,LRRK2,missense,MOD_PKA_2,49-55,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs61747727,NPHS2,missense,MOD_PKA_2,237-243,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs59588658,ABCC6,missense,MOD_PKA_2,1417-1423,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs573249154,STX11,missense,MOD_PKA_2,77-83,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs574303164,ABCC6,missense,MOD_PKA_2,1046-1052,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs146396982,KCNJ10,missense,MOD_PKA_2,342-348,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs35641839,MYO7A,missense,MOD_PKA_2,674-680,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs548262562,KRT14,missense,MOD_PKA_2,29-35,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs554887705,NOD2,missense,MOD_PKA_2,386-392,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs553523967,BMPR2,missense,MOD_PKA_2,356-362,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs190624231,MYO7A,missense,MOD_PKA_2,701-707,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs183015712,BBS9,missense,MOD_PKA_2,586-592,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs61736659,PYGM,missense,MOD_PKA_2,649-655,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs201003237,LAMB3,missense,MOD_PKA_2,885-891,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs41308954,KCNH2,missense,MOD_PKA_2,175-181,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs137853074,KCNJ10,missense,MOD_PKA_2,342-348,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs114904237,TMPRSS3,missense,MOD_PKA_2,435-441,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs201988582,CEP290,missense,MOD_PKA_2,359-365,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs566081370,SCN1A,missense,MOD_PKA_2,1207-1213,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs547608599,FOXI1,missense,MOD_PKA_2,45-51,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs147371999,CEP290,missense,MOD_PKA_2,520-526,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs144744401,UNC13D,missense,MOD_PKA_2,965-971,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs41313697,SCN5A,missense,MOD_ProDKin_1,461-467,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs183518211,BMPR2,missense,MOD_ProDKin_1,572-578,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201690512,OTUD4,missense,MOD_ProDKin_1,568-574,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs573797955,CPOX,missense,MOD_ProDKin_1,281-287,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs529018971,RET,missense,MOD_ProDKin_1,45-51,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs150140303,IL10RA,missense,MOD_ProDKin_1,25-31,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs41272435,CHD7,missense,MOD_ProDKin_1,97-103,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs569249595,HNF1A,missense,MOD_ProDKin_1,343-349,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs569249595,HNF1A,missense,MOD_ProDKin_1,349-355,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201745292,CPT2,missense,MOD_ProDKin_1,391-397,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201745292,CPT2,missense,MOD_ProDKin_1,395-401,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs535392006,FLRT3,missense,MOD_ProDKin_1,490-496,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs531924876,COL17A1,missense,MOD_ProDKin_1,264-270,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201831535,SCN5A,missense,MOD_ProDKin_1,1035-1041,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs541584830,PDX1,missense,MOD_ProDKin_1,265-271,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs192540254,CEP290,missense,MOD_ProDKin_1,2455-2461,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs191435594,CHD7,missense,MOD_ProDKin_1,389-395,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs139420743,FOXI1,missense,MOD_ProDKin_1,253-259,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs140918872,NOD2,missense,MOD_ProDKin_1,393-399,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs61340537,ABCC6,missense,MOD_ProDKin_1,941-947,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs200313391,MYO7A,missense,MOD_ProDKin_1,2070-2076,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs115737075,RNF216,missense,MOD_ProDKin_1,45-51,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs199473030,KCNH2,missense,MOD_ProDKin_1,1095-1101,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs183443251,MYO7A,missense,MOD_ProDKin_1,346-352,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201860939,BBS2,missense,MOD_ProDKin_1,57-63,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs114544692,LAMB3,missense,MOD_ProDKin_1,794-800,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs58559150,LRRK2,missense,MOD_ProDKin_1,923-929,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs189794855,KCNQ1,missense,MOD_ProDKin_1,495-501,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs536357058,RBM20,missense,MOD_ProDKin_1,82-88,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs567793250,NOD2,missense,MOD_ProDKin_1,20-26,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs551271865,OTUD4,missense,MOD_ProDKin_1,489-495,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs373652923,DFNB31,missense,MOD_ProDKin_1,625-631,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs140018525,F5,missense,MOD_ProDKin_1,1274-1280,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs143456081,CPOX,missense,MOD_ProDKin_1,429-435,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs559222331,MITF,missense,MOD_ProDKin_1,92-98,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs546997981,NPHS1,missense,MOD_ProDKin_1,686-692,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs558693763,LAMA1,missense,MOD_ProDKin_1,2230-2236,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs200996196,LAMA1,missense,MOD_ProDKin_1,2815-2821,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs188054898,RBM20,missense,MOD_ProDKin_1,1057-1063,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201556325,F5,missense,MOD_ProDKin_1,1687-1693,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs534523640,DFNB31,missense,MOD_ProDKin_1,682-688,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs141168514,DFNB31,missense,MOD_ProDKin_1,625-631,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201810995,LRRK2,missense,MOD_ProDKin_1,923-929,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs563657853,LRP5,missense,MOD_ProDKin_1,1427-1433,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs150232968,PYGM,missense,MOD_ProDKin_1,226-232,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs147356378,RBM20,missense,MOD_ProDKin_1,1084-1090,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs140716236,NOD2,missense,MOD_ProDKin_1,393-399,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201804583,PRF1,missense,MOD_ProDKin_1,133-139,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs200960909,TYR,missense,MOD_ProDKin_1,41-47,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs61753180,TYR,missense,MOD_ProDKin_1,41-47,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs576666901,IL10RA,missense,MOD_ProDKin_1,283-289,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs115148599,F5,missense,MOD_ProDKin_1,1436-1442,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs572609043,DFNB31,missense,MOD_ProDKin_1,652-658,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs147680216,WNT10A,missense,MOD_ProDKin_1,212-218,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs77811721,LAMA1,missense,MOD_ProDKin_1,144-150,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs150050676,LRRK2,missense,MOD_GlcNHglycan,243-246,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs148708451,KCNA5,missense,MOD_GlcNHglycan,300-303,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs555466415,MYO7A,missense,MOD_GlcNHglycan,1275-1278,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs201926546,RNF216,missense,MOD_GlcNHglycan,120-123,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs9456735,PARK2,missense,MOD_GlcNHglycan,192-195,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs544908256,KCNA5,missense,MOD_GlcNHglycan,300-303,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs372505798,MYH7B,missense,MOD_GlcNHglycan,1250-1253,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs199653619,OTUD4,missense,MOD_GlcNHglycan,161-164,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs141722672,BAAT,missense,MOD_GlcNHglycan,226-229,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs145417931,LAMA1,missense,MOD_GlcNHglycan,850-854,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs145417931,LAMA1,missense,MOD_GlcNHglycan,851-854,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs201154610,LAMB3,missense,MOD_GlcNHglycan,549-552,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs185505138,CHD7,missense,MOD_GlcNHglycan,2158-2161,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs114615449,NPHS1,missense,MOD_GlcNHglycan,601-604,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs199655229,ALAD,missense,MOD_GlcNHglycan,8-11,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs1130183,KCNJ10,missense,MOD_GlcNHglycan,271-274,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs561821477,CHD7,missense,MOD_GlcNHglycan,1442-1445,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs112194576,LAMA1,missense,MOD_GlcNHglycan,219-222,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs555255264,NPHS1,missense,MOD_GlcNHglycan,1185-1188,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs548754771,DSP,missense,MOD_GlcNHglycan,2826-2829,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs41302885,DSP,missense,MOD_GlcNHglycan,2070-2073,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs573426783,RBM20,missense,MOD_GlcNHglycan,12-16,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs191807913,NPHS1,missense,MOD_GlcNHglycan,670-673,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs3795339,KCNJ10,missense,MOD_GlcNHglycan,271-274,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs551068385,SCN1A,missense,MOD_GlcNHglycan,212-215,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs200951928,TYR,missense,MOD_GlcNHglycan,91-94,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs563657853,LRP5,missense,MOD_GlcNHglycan,1427-1430,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs377651588,COL17A1,missense,MOD_GlcNHglycan,399-402,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs148526538,KRT5,missense,MOD_GlcNHglycan,10-13,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs200960909,TYR,missense,MOD_GlcNHglycan,39-42,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs41308954,KCNH2,missense,MOD_GlcNHglycan,181-184,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs150384293,BBS2,missense,MOD_GlcNHglycan,286-289,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs138018628,PINK1,missense,MOD_GlcNHglycan,224-227,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs200203992,FGA,missense,MOD_GlcNHglycan,299-302,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs563762318,RBM20,missense,MOD_GlcNHglycan,1182-1185,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs4252250,IL10RA,missense,LIG_SUMO_SIM_anti_2,58-63,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs200093674,SLC3A1,missense,LIG_SUMO_SIM_anti_2,104-109,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs187746691,OTUD4,missense,LIG_SUMO_SIM_anti_2,42-48,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs149233226,SLC45A2,missense,LIG_SUMO_SIM_anti_2,503-510,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs552752095,CPOX,missense,LIG_SUMO_SIM_anti_2,206-211,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs75813654,KCNQ1,missense,LIG_SUMO_SIM_anti_2,202-209,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs200882666,KCNA5,missense,LIG_SUMO_SIM_anti_2,2-7,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs537423012,SCN5A,missense,DOC_CYCLIN_1,1306-1310,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs573577248,LAMB3,missense,DOC_CYCLIN_1,1164-1168,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs147415451,DSP,missense,DOC_CYCLIN_1,1725-1729,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs561518392,LAMA1,missense,DOC_CYCLIN_1,1394-1397,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs142293185,MYO7A,missense,DOC_CYCLIN_1,1952-1956,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs533669726,KCNQ1,missense,DOC_CYCLIN_1,237-241,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs144696430,BBS4,missense,DOC_CYCLIN_1,109-113,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs533618528,NOD2,missense,DOC_CYCLIN_1,760-764,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs561452524,DSP,missense,DOC_CYCLIN_1,2113-2116,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs181121175,CEP290,missense,DOC_CYCLIN_1,1363-1366,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs573272388,POLG,missense,DOC_CYCLIN_1,1117-1120,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs59157279,ABCC6,missense,DOC_CYCLIN_1,513-517,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs201003237,LAMB3,missense,DOC_CYCLIN_1,889-892,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs571028191,FLRT3,missense,DOC_CYCLIN_1,107-111,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs140967646,SCN5A,missense,DOC_CYCLIN_1,968-972,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs536528003,MYO7A,missense,LIG_LIR_Nem_3,1944-1949,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs111033186,GJB2,missense,LIG_LIR_Nem_3,147-153,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs144429570,LAMA1,missense,LIG_LIR_Nem_3,725-730,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs557323479,UNC13D,missense,LIG_LIR_Nem_3,523-529,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs12720457,KCNQ1,missense,LIG_LIR_Nem_3,389-395,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs12720457,KCNQ1,missense,LIG_LIR_Nem_3,390-395,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs12720457,KCNQ1,missense,LIG_LIR_Nem_3,391-395,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs372768607,MYO7A,missense,LIG_LIR_Nem_3,1831-1837,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs548208395,SLC26A4,missense,LIG_LIR_Nem_3,569-575,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs143273384,ATP2B3,missense,LIG_LIR_Nem_3,492-498,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs143273384,ATP2B3,missense,LIG_LIR_Nem_3,493-498,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs567877611,RET,missense,LIG_LIR_Nem_3,104-109,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs567877611,RET,missense,LIG_LIR_Nem_3,105-109,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs2856897,MYH7,missense,LIG_LIR_Nem_3,854-859,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs2856897,MYH7,missense,LIG_LIR_Nem_3,855-859,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs201161067,PYGM,missense,LIG_LIR_Nem_3,757-762,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs186982468,NEK1,missense,LIG_LIR_Nem_3,406-412,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs545065102,SGCB,missense,LIG_LIR_Nem_3,279-285,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs545065102,SGCB,missense,LIG_LIR_Nem_3,281-285,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs550863556,CD2AP,missense,LIG_LIR_Nem_3,358-364,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs569609298,CPT2,missense,LIG_LIR_Nem_3,576-582,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs139719799,BBS10,missense,LIG_LIR_Nem_3,556-562,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs567750476,BBS9,missense,LIG_LIR_Nem_3,753-759,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs540032875,NEK1,missense,LIG_LIR_Nem_3,107-112,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs142482973,SLC3A1,missense,LIG_LIR_Nem_3,178-183,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs142482973,SLC3A1,missense,LIG_LIR_Nem_3,179-183,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs199989979,MYO7A,missense,LIG_LIR_Nem_3,8-14,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs199655229,ALAD,missense,LIG_LIR_Nem_3,9-15,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs551000865,NEK1,missense,LIG_LIR_Nem_3,406-412,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs121908480,SLC7A9,missense,LIG_LIR_Nem_3,102-107,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs530925237,RBM20,missense,LIG_LIR_Nem_3,401-405,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs143092783,NPHS1,missense,LIG_LIR_Nem_3,1136-1142,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs115109291,POLG,missense,LIG_LIR_Nem_3,136-142,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs116840776,CAV3,missense,LIG_LIR_Nem_3,68-73,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs144249951,LAMB3,missense,LIG_LIR_Nem_3,521-527,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs112194576,LAMA1,missense,LIG_LIR_Nem_3,220-226,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs148732080,TACR3,missense,LIG_LIR_Nem_3,246-250,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs565923862,FGG,missense,LIG_LIR_Nem_3,285-291,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs565923862,FGG,missense,LIG_LIR_Nem_3,287-291,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs191246968,CEP41,missense,LIG_LIR_Nem_3,241-247,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs375200566,MYO7A,missense,LIG_LIR_Nem_3,249-255,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs570284670,LAMA1,missense,LIG_LIR_Nem_3,643-648,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs532361142,BBS2,missense,LIG_LIR_Nem_3,642-647,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs574204412,NEK1,missense,LIG_LIR_Nem_3,444-449,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs142790819,SLC3A1,missense,LIG_LIR_Nem_3,423-428,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs149026031,F5,missense,LIG_LIR_Nem_3,1053-1059,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs149026031,F5,missense,LIG_LIR_Nem_3,1054-1059,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs199473054,SCN5A,missense,LIG_LIR_Nem_3,92-96,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs200951928,TYR,missense,LIG_LIR_Nem_3,92-98,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs202238753,RBM20,missense,LIG_LIR_Nem_3,225-231,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs559363120,PYGM,missense,LIG_LIR_Nem_3,731-736,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs35641839,MYO7A,missense,LIG_LIR_Nem_3,677-681,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs557802902,BBS10,missense,LIG_LIR_Nem_3,215-221,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs557802902,BBS10,missense,LIG_LIR_Nem_3,216-221,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs566907093,KCNQ1,missense,LIG_LIR_Nem_3,264-270,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs143309797,C10orf2,missense,LIG_LIR_Nem_3,369-373,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs145289229,POLG,missense,LIG_LIR_Nem_3,387-392,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs143634778,IL17RD,missense,LIG_LIR_Nem_3,327-333,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs201709367,NOD2,missense,LIG_LIR_Nem_3,685-690,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs142153692,KCNE2,missense,LIG_LIR_Nem_3,12-18,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs142153692,KCNE2,missense,LIG_LIR_Nem_3,13-18,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs577367079,PRF1,missense,LIG_LIR_Nem_3,466-470,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs142692981,BBS4,missense,LIG_LIR_Nem_3,67-71,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs34320941,KCNQ1,missense,LIG_LIR_Nem_3,295-299,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs376100751,LAMA1,missense,LIG_LIR_Nem_3,2974-2980,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs145017164,PCDH15,missense,LIG_LIR_Nem_3,399-403,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs192332456,CPOX,missense,LIG_LIR_Nem_3,90-96,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs114174766,LAMB3,missense,LIG_LIR_Nem_3,712-718,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs186298636,RNF216,missense,LIG_LIR_Nem_3,108-113,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs186298636,RNF216,missense,LIG_LIR_Nem_3,109-113,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs532317198,UNC13D,missense,LIG_LIR_Nem_3,191-195,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs114293092,FOXI1,missense,LIG_LIR_Nem_3,106-112,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs566081370,SCN1A,missense,LIG_LIR_Nem_3,1210-1215,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs527378833,CHD7,missense,LIG_LIR_Nem_3,44-50,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs572609043,DFNB31,missense,LIG_LIR_Nem_3,648-654,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs201194028,BBS10,missense,LIG_LIR_Nem_3,124-129,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs536528003,MYO7A,missense,LIG_UBA3_1,1945-1952,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs138877178,F5,missense,LIG_UBA3_1,1811-1819,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs200359303,MYO7A,missense,LIG_UBA3_1,2201-2207,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs201240407,MFN2,missense,LIG_UBA3_1,497-502,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs542347980,F5,missense,LIG_UBA3_1,1811-1819,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs200949139,PINK1,missense,LIG_UBA3_1,314-319,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs576084212,MTR,missense,LIG_UBA3_1,712-717,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs568743605,JUP,missense,LIG_UBA3_1,219-224,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs192129249,CHD7,missense,LIG_UBA3_1,2524-2530,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs540699814,DFNB31,missense,LIG_UBA3_1,463-472,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs116483694,BBS9,missense,LIG_UBA3_1,735-743,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs116483694,BBS9,missense,LIG_UBA3_1,736-743,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs116483694,BBS9,missense,LIG_UBA3_1,737-743,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs183387506,CEP290,missense,LIG_UBA3_1,2358-2366,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs6034,F5,missense,LIG_UBA3_1,1744-1753,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs77018758,LRRK2,missense,LIG_UBA3_1,1318-1327,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs200390101,GDAP1,missense,LIG_UBA3_1,208-214,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs111033186,GJB2,missense,LIG_Pex14_2,150-154,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs536296269,KRT14,missense,LIG_Pex14_2,100-104,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs150397427,TMPRSS3,missense,LIG_Pex14_2,165-169,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs137900287,KAL1,missense,LIG_Pex14_2,585-589,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs556510021,PCDH15,missense,LIG_Pex14_2,759-763,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs565278457,SLC45A2,missense,LIG_Pex14_2,521-525,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs111033186,GJB2,missense,LIG_SH2_STAT5,152-155,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs200565677,CHD7,missense,LIG_SH2_STAT5,1062-1065,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs201553718,RET,missense,LIG_SH2_STAT5,508-511,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs199673903,CPT2,missense,LIG_SH2_STAT5,252-255,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs574875874,TACR3,missense,LIG_SH2_STAT5,157-160,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs374655803,MYO7A,missense,LIG_SH2_STAT5,1668-1671,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs148388884,GJB3,missense,LIG_SH2_STAT5,36-39,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs369588002,C10orf2,missense,LIG_SH2_STAT5,506-509,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs141499220,UNC13D,missense,LIG_SH2_STAT5,298-301,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs201745826,RET,missense,LIG_SH2_STAT5,508-511,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs182025062,OTUD4,missense,LIG_SH2_STAT5,655-658,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs138231868,SCN1A,missense,LIG_SH2_STAT5,1462-1465,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs547308774,RET,missense,LIG_SH2_STAT5,52-55,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs546681165,FLRT3,missense,LIG_SH2_STAT5,551-554,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs187406481,TMPRSS3,missense,LIG_SH2_STAT5,150-153,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs528946101,TTC8,missense,LIG_SH2_STAT5,485-488,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs564138835,TYR,missense,LIG_SH2_STAT5,451-454,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs202039659,HNF1A,missense,LIG_SH2_STAT5,512-515,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs543856218,ROM1,missense,LIG_SH2_STAT5,309-312,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs559720365,TYR,missense,LIG_SH2_STAT5,137-140,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs138744722,SLC7A9,missense,LIG_SH2_STAT5,175-178,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs148508128,GDAP1,missense,LIG_SH2_STAT5,185-188,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs145237292,CPT2,missense,LIG_SH2_STAT5,290-293,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs201920792,F5,missense,LIG_SH2_STAT5,2149-2152,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs141459368,RET,missense,LIG_SH2_STAT5,864-867,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs563657853,LRP5,missense,LIG_SH2_STAT5,1426-1429,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs575509512,NOD2,missense,LIG_SH2_STAT5,821-824,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs186298636,RNF216,missense,LIG_SH2_STAT5,110-113,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs189633442,OCA2,missense,LIG_SH2_STAT5,703-706,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs114904237,TMPRSS3,missense,LIG_SH2_STAT5,434-437,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs144691638,SCN1A,missense,DOC_USP7_MATH_1,1855-1859,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs148708451,KCNA5,missense,DOC_USP7_MATH_1,298-302,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs544908256,KCNA5,missense,DOC_USP7_MATH_1,298-302,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs372505798,MYH7B,missense,DOC_USP7_MATH_1,1248-1252,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs200500057,LAMA1,missense,DOC_USP7_MATH_1,401-405,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs576816351,COL17A1,missense,DOC_USP7_MATH_1,1276-1280,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs372321135,CYP1B1,missense,DOC_USP7_MATH_1,305-309,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs146957466,BMPR2,missense,DOC_USP7_MATH_1,425-429,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs115812503,LAMB3,missense,DOC_USP7_MATH_1,267-271,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs200188533,KRT5,missense,DOC_USP7_MATH_1,525-529,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs541584830,PDX1,missense,DOC_USP7_MATH_1,269-273,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs1130183,KCNJ10,missense,DOC_USP7_MATH_1,269-273,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs529360617,PARK2,missense,DOC_USP7_MATH_1,113-117,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs532380776,STXBP2,missense,DOC_USP7_MATH_1,67-71,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs201860939,BBS2,missense,DOC_USP7_MATH_1,61-65,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs568157731,LRRK2,missense,DOC_USP7_MATH_1,1022-1026,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs573426783,RBM20,missense,DOC_USP7_MATH_1,11-15,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs150036969,ABCC9,missense,DOC_USP7_MATH_1,627-631,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs549851479,LRRK2,missense,DOC_USP7_MATH_1,1464-1468,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs3795339,KCNJ10,missense,DOC_USP7_MATH_1,269-273,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs149026031,F5,missense,DOC_USP7_MATH_1,1050-1054,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs545872093,NPHS2,missense,DOC_USP7_MATH_1,43-47,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs367976914,NPHS1,missense,DOC_USP7_MATH_1,604-608,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs140133975,RNF216,missense,DOC_USP7_MATH_1,96-100,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs199946321,LAMB3,missense,DOC_USP7_MATH_1,876-880,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs201033964,RNF216,missense,DOC_USP7_MATH_1,96-100,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs138018628,PINK1,missense,DOC_USP7_MATH_1,226-230,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs2277596,BBS4,missense,DOC_USP7_MATH_1,471-475,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs143908409,OTUD4,missense,DOC_USP7_MATH_1,482-486,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs538707626,MTR,missense,MOD_N-GLC_2,118-120,,ELME000079,N-glycosylation site,"Atipical motif for N-glycosylation site. Examples are Human CD69, which is uniquely glycosylated at typical (Asn-X-Ser/Thr) and atypical (Asn-X-Cys) motifs, beta protein C",(N)[^P]C,0.0002972992,5,0
rs61732295,GJB3,missense,MOD_N-GLC_2,62-64,,ELME000079,N-glycosylation site,"Atipical motif for N-glycosylation site. Examples are Human CD69, which is uniquely glycosylated at typical (Asn-X-Ser/Thr) and atypical (Asn-X-Cys) motifs, beta protein C",(N)[^P]C,0.0002972992,5,0
rs564187115,LAMA1,missense,MOD_N-GLC_2,1130-1132,,ELME000079,N-glycosylation site,"Atipical motif for N-glycosylation site. Examples are Human CD69, which is uniquely glycosylated at typical (Asn-X-Ser/Thr) and atypical (Asn-X-Cys) motifs, beta protein C",(N)[^P]C,0.0002972992,5,0
rs200800189,ABCC6,missense,MOD_N-GLC_2,710-712,,ELME000079,N-glycosylation site,"Atipical motif for N-glycosylation site. Examples are Human CD69, which is uniquely glycosylated at typical (Asn-X-Ser/Thr) and atypical (Asn-X-Cys) motifs, beta protein C",(N)[^P]C,0.0002972992,5,0
rs200856491,SCN1A,missense,MOD_PKB_1,710-718,,ELME000061,PKB Phosphorylation site,PKB Phosphorylation site,R.R..([ST])[^P]..,0.0006034092,20,1
rs150924946,LMNA,missense,MOD_PKB_1,296-304,,ELME000061,PKB Phosphorylation site,PKB Phosphorylation site,R.R..([ST])[^P]..,0.0006034092,20,1
rs549888974,OTUD4,missense,MOD_PKB_1,439-447,,ELME000061,PKB Phosphorylation site,PKB Phosphorylation site,R.R..([ST])[^P]..,0.0006034092,20,1
rs546272425,LMNA,missense,MOD_PKB_1,296-304,,ELME000061,PKB Phosphorylation site,PKB Phosphorylation site,R.R..([ST])[^P]..,0.0006034092,20,1
rs200856491,SCN1A,missense,MOD_PK_1,712-718,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs555763808,OTUD4,missense,MOD_PK_1,209-215,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs142293185,MYO7A,missense,MOD_PK_1,1952-1958,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs573249154,STX11,missense,MOD_PK_1,78-84,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs548262562,KRT14,missense,MOD_PK_1,30-36,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs41308954,KCNH2,missense,MOD_PK_1,176-182,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs200565677,CHD7,missense,LIG_LIR_Apic_2,1060-1066,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs374655803,MYO7A,missense,LIG_LIR_Apic_2,1665-1671,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs374655803,MYO7A,missense,LIG_LIR_Apic_2,1666-1671,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs182025062,OTUD4,missense,LIG_LIR_Apic_2,654-658,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs41272435,CHD7,missense,LIG_LIR_Apic_2,103-108,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs191435594,CHD7,missense,LIG_LIR_Apic_2,389-393,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs199655229,ALAD,missense,LIG_LIR_Apic_2,9-14,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs147219463,CPOX,missense,LIG_LIR_Apic_2,128-133,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs147219463,CPOX,missense,LIG_LIR_Apic_2,129-133,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs549481773,F5,missense,LIG_LIR_Apic_2,2029-2035,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs543856218,ROM1,missense,LIG_LIR_Apic_2,306-312,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs146396982,KCNJ10,missense,LIG_LIR_Apic_2,346-352,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs555661808,LAMA1,missense,LIG_LIR_Apic_2,817-821,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs574291969,LAMB3,missense,LIG_LIR_Apic_2,122-126,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs137853074,KCNJ10,missense,LIG_LIR_Apic_2,346-352,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs139445116,COL17A1,missense,LIG_LIR_Apic_2,255-260,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs111033527,SLC26A4,missense,LIG_TRAF2_1,411-414,,ELME000117,TRAF2 binding site,Major TRAF2-binding consensus motif. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails.,[PSAT].[QE]E,0.0042998127,14,6
rs573410951,LAMB3,missense,LIG_TRAF2_1,908-911,,ELME000117,TRAF2 binding site,Major TRAF2-binding consensus motif. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails.,[PSAT].[QE]E,0.0042998127,14,6
rs139571975,NOD2,missense,LIG_KLC1_WD_1,155-162,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs567877611,RET,missense,LIG_KLC1_WD_1,104-111,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs150062967,LRRK2,missense,LIG_KLC1_WD_1,2494-2501,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs200570629,SLC3A1,missense,LIG_KLC1_WD_1,509-517,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs199810018,PARK2,missense,LIG_KLC1_WD_1,181-189,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs147641617,NPHS1,missense,LIG_KLC1_WD_1,578-587,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs138366708,JUP,missense,LIG_KLC1_WD_1,678-687,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs200048973,PROKR2,missense,LIG_KLC1_WD_1,119-127,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs576380462,NPHS1,missense,LIG_HCF-1_HBM_1,891-894,,ELME000302,HCF-1 binding motif,The DHxY Host Cell Factor-1 binding motif (HBM) interacts with the N-terminal kelch propeller domain of the cell cycle regulator HCF-1,[DE]H.Y,5.073861324e-05,17,0
rs571810545,TYR,missense,TRG_NES_CRM1_1,174-186,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs201161067,PYGM,missense,TRG_NES_CRM1_1,757-770,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs557790670,CCDC28B,missense,TRG_NES_CRM1_1,177-190,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs557790670,CCDC28B,missense,TRG_NES_CRM1_1,178-190,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs546641348,SCN1A,missense,TRG_NES_CRM1_1,168-182,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs199798449,MYO6,missense,TRG_NES_CRM1_1,336-351,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs145564837,MYO6,missense,TRG_NES_CRM1_1,336-351,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs145170911,RET,missense,TRG_NES_CRM1_1,860-874,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs201576246,LRP5,missense,TRG_NES_CRM1_1,543-556,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs537781874,UNC13D,missense,TRG_NES_CRM1_1,80-95,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs190548494,PYGM,missense,TRG_NES_CRM1_1,757-770,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs537456337,GGCX,missense,TRG_NES_CRM1_1,361-373,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs141459368,RET,missense,TRG_NES_CRM1_1,860-874,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs138487695,TYR,missense,TRG_NES_CRM1_1,174-186,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs369544574,POLG,missense,TRG_NES_CRM1_1,1184-1196,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs571406176,RBM20,missense,MOD_SUMO_rev_2,1005-1011,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs148642312,RNF216,missense,MOD_SUMO_rev_2,535-543,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs148642312,RNF216,missense,MOD_SUMO_rev_2,537-543,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs575143221,STXBP2,missense,MOD_SUMO_rev_2,21-31,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs144814658,SCN2A,missense,MOD_SUMO_rev_2,26-34,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs550863556,CD2AP,missense,MOD_SUMO_rev_2,353-362,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs200103404,NPHS2,missense,MOD_SUMO_rev_2,233-241,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs576975311,F5,missense,MOD_SUMO_rev_2,2158-2166,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs576975311,F5,missense,MOD_SUMO_rev_2,2159-2166,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs556237236,LMNA,missense,MOD_SUMO_rev_2,107-116,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs563272521,CHD7,missense,MOD_SUMO_rev_2,946-956,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs2234927,MYOC,missense,MOD_SUMO_rev_2,208-217,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs61747727,NPHS2,missense,MOD_SUMO_rev_2,240-248,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs551271865,OTUD4,missense,MOD_SUMO_rev_2,489-499,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs551271865,OTUD4,missense,MOD_SUMO_rev_2,492-499,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs536486113,RET,missense,MOD_SUMO_rev_2,1054-1061,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs138893547,CPT2,missense,MOD_SUMO_rev_2,646-656,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs138893547,CPT2,missense,MOD_SUMO_rev_2,649-656,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs367987327,DSP,missense,MOD_SUMO_rev_2,468-476,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs184648701,SLC3A1,missense,MOD_SUMO_rev_2,433-441,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs201635937,LAMA1,missense,MOD_SUMO_rev_2,917-925,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs114849139,NPHS1,missense,MOD_SUMO_rev_2,956-963,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs201326686,MYH7,missense,MOD_SUMO_rev_2,1550-1559,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs201326686,MYH7,missense,MOD_SUMO_rev_2,1552-1559,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs201326686,MYH7,missense,MOD_SUMO_rev_2,1554-1559,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs140234450,CCDC28B,missense,MOD_SUMO_rev_2,154-163,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs200193213,LAMA1,missense,MOD_SUMO_rev_2,475-481,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs147459176,GJB3,missense,MOD_SUMO_rev_2,41-51,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs147415451,DSP,missense,LIG_Actin_WH2_2,1720-1737,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs147239130,MYH7B,missense,LIG_Actin_WH2_2,1797-1815,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs374778258,ABCC6,missense,LIG_Actin_WH2_2,48-66,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs575447822,CPT2,missense,LIG_Actin_WH2_2,408-426,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs543621728,CEP290,missense,LIG_Actin_WH2_2,1321-1338,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs372563120,BAAT,missense,LIG_Actin_WH2_2,235-251,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs540032875,NEK1,missense,LIG_Actin_WH2_2,103-119,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs80358317,LRP5,missense,LIG_Actin_WH2_2,1119-1136,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs530073662,ABCC6,missense,LIG_Actin_WH2_2,367-384,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs2229467,LAMB3,missense,LIG_Actin_WH2_2,973-990,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs144591246,BAAT,missense,LIG_Actin_WH2_2,133-150,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs548101215,UNC13D,missense,LIG_Actin_WH2_2,693-711,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs548101215,UNC13D,missense,LIG_Actin_WH2_2,694-711,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs548101215,UNC13D,missense,LIG_Actin_WH2_2,695-711,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs140769823,LAMB3,missense,LIG_Actin_WH2_2,973-990,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs59588658,ABCC6,missense,LIG_Actin_WH2_2,1405-1420,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs187406481,TMPRSS3,missense,LIG_Actin_WH2_2,144-159,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs200270332,LAMB3,missense,LIG_Actin_WH2_2,1008-1025,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs372364561,JUP,missense,LIG_Actin_WH2_2,109-126,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs529138303,MYOC,missense,LIG_Actin_WH2_2,215-231,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs188516326,DSP,missense,LIG_Actin_WH2_2,80-96,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs199588131,SLC26A4,missense,LIG_Actin_WH2_2,661-679,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs202157653,LAMA1,missense,LIG_Actin_WH2_2,573-590,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs59157279,ABCC6,missense,LIG_Actin_WH2_2,510-528,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs201831309,LAMA1,missense,LIG_Actin_WH2_2,1081-1097,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs529219961,OCA2,missense,LIG_Actin_WH2_2,311-326,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs150765531,TMPRSS3,missense,LIG_Actin_WH2_2,11-27,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs199473180,SCN5A,missense,LIG_Actin_WH2_2,956-973,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs140967646,SCN5A,missense,LIG_Actin_WH2_2,956-973,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs144429570,LAMA1,missense,LIG_EH1_1,727-735,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs138877178,F5,missense,LIG_EH1_1,1805-1813,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs190761354,ABCC6,missense,LIG_EH1_1,585-593,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs201165795,CPT2,missense,LIG_EH1_1,329-337,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs80338949,GJB2,missense,LIG_EH1_1,160-168,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs142516093,MYO6,missense,LIG_EH1_1,15-23,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs111033360,GJB2,missense,LIG_EH1_1,160-168,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs542347980,F5,missense,LIG_EH1_1,1805-1813,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs2229274,MTR,missense,LIG_EH1_1,310-318,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs148732080,TACR3,missense,LIG_EH1_1,246-254,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs148732080,TACR3,missense,LIG_EH1_1,247-255,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs104895447,NOD2,missense,LIG_EH1_1,860-868,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs558508305,ABCC6,missense,LIG_EH1_1,550-558,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs542835031,KCNE2,missense,LIG_EH1_1,61-69,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs116483694,BBS9,missense,LIG_EH1_1,731-739,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs144429570,LAMA1,missense,TRG_ENDOCYTIC_2,727-730,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs574875874,TACR3,missense,TRG_ENDOCYTIC_2,157-160,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs143273384,ATP2B3,missense,TRG_ENDOCYTIC_2,495-498,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs138231868,SCN1A,missense,TRG_ENDOCYTIC_2,1462-1465,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs569609298,CPT2,missense,TRG_ENDOCYTIC_2,579-582,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs121908480,SLC7A9,missense,TRG_ENDOCYTIC_2,104-107,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs143092783,NPHS1,missense,TRG_ENDOCYTIC_2,1139-1142,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs148732080,TACR3,missense,TRG_ENDOCYTIC_2,247-250,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs565923862,FGG,missense,TRG_ENDOCYTIC_2,288-291,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs371157150,CEP290,missense,TRG_ENDOCYTIC_2,1559-1562,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs375200566,MYO7A,missense,TRG_ENDOCYTIC_2,252-255,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs121917910,SCN1A,missense,TRG_ENDOCYTIC_2,1306-1309,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs147835286,PCDH15,missense,TRG_ENDOCYTIC_2,1176-1179,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs11104729,CEP290,missense,TRG_ENDOCYTIC_2,1833-1836,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs575996895,FOXC1,missense,TRG_ENDOCYTIC_2,105-108,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs559363120,PYGM,missense,TRG_ENDOCYTIC_2,733-736,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs35641839,MYO7A,missense,TRG_ENDOCYTIC_2,676-679,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs559720365,TYR,missense,TRG_ENDOCYTIC_2,137-140,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs147231991,TMPRSS3,missense,TRG_ENDOCYTIC_2,137-140,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs186298636,RNF216,missense,TRG_ENDOCYTIC_2,110-113,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs201090454,FOXI1,missense,TRG_ENDOCYTIC_2,361-364,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs577102638,CEP41,missense,TRG_ENDOCYTIC_2,23-26,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs114904237,TMPRSS3,missense,TRG_ENDOCYTIC_2,434-437,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs200844919,MYO7A,missense,TRG_ENDOCYTIC_2,403-406,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs572609043,DFNB31,missense,TRG_ENDOCYTIC_2,651-654,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs538329630,IL17RD,missense,TRG_NLS_MonoExtN_4,241-247,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs144814658,SCN2A,missense,TRG_NLS_MonoExtN_4,33-39,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs61754402,PRPH2,missense,TRG_NLS_MonoExtN_4,11-16,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs140133975,RNF216,missense,TRG_NLS_MonoExtN_4,95-101,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs140133975,RNF216,missense,TRG_NLS_MonoExtN_4,96-101,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs201033964,RNF216,missense,TRG_NLS_MonoExtN_4,95-101,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs201033964,RNF216,missense,TRG_NLS_MonoExtN_4,96-101,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs192378817,MYO7A,missense,TRG_NLS_MonoExtN_4,1117-1122,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs144199299,GDAP1,missense,TRG_NLS_MonoExtN_4,188-194,,ELME000271,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. N-extended version.,"(([PKR].{0,1}[^DE])|([PKR]))((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0012763875,26,2
rs548960999,SLC3A1,missense,LIG_PAM2_1,309-321,,ELME000303,PAM2 motif,"Peptide ligand motif that directly binds to the MLLE/PABC domain found in poly(A)-binding proteins and HYD E3 ubiquitin ligases, mainly via a common central core region and a complementary N-terminal region.",..[LFP][NS][PIVTAFL].A..(([FY].[PYLF])|(W..)).,9.95389535837e-06,22,6
rs146288080,PARK2,missense,DOC_USP7_MATH_2,14-20,,ELME000240,USP7 binding motif,The USP7 MATH domain binding motif variant based on the EBV EBNA1 interaction.,P.E[^P].S[^P],0.0007168714,1,1
rs563657853,LRP5,missense,DOC_USP7_MATH_2,1423-1429,,ELME000240,USP7 binding motif,The USP7 MATH domain binding motif variant based on the EBV EBNA1 interaction.,P.E[^P].S[^P],0.0007168714,1,1
rs557323479,UNC13D,missense,DOC_PP1_RVXF_1,525-532,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs575447822,CPT2,missense,DOC_PP1_RVXF_1,412-418,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs371412500,OCA2,missense,DOC_PP1_RVXF_1,674-680,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs57179857,ABCC6,missense,DOC_PP1_RVXF_1,1016-1022,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs57179857,ABCC6,missense,DOC_PP1_RVXF_1,1021-1027,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs184046644,UNC13D,missense,DOC_PP1_RVXF_1,643-650,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs541139673,MYO7A,missense,DOC_PP1_RVXF_1,814-821,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs555529285,DSP,missense,DOC_PP1_RVXF_1,870-877,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs562257866,SLC3A1,missense,DOC_PP1_RVXF_1,84-91,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs375968699,CPT2,missense,DOC_PP1_RVXF_1,188-195,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs562616743,LRP5,missense,DOC_PP1_RVXF_1,1163-1170,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs34320941,KCNQ1,missense,DOC_PP1_RVXF_1,291-297,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs41278630,MFN2,missense,DOC_PP1_RVXF_1,298-304,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs529063316,SCN2A,missense,DOC_PP1_RVXF_1,275-282,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs369227219,CEP290,missense,DOC_PP1_RVXF_1,1341-1348,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs546883829,POLG,missense,DOC_PP1_RVXF_1,988-995,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs200338012,DSP,missense,DOC_PP1_RVXF_1,870-877,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs140967646,SCN5A,missense,DOC_PP1_RVXF_1,966-973,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs557323479,UNC13D,missense,TRG_LysEnd_APsAcLL_1,528-533,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs372768607,MYO7A,missense,TRG_LysEnd_APsAcLL_1,1832-1837,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs555797304,KCNH2,missense,TRG_LysEnd_APsAcLL_1,1069-1074,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs144696430,BBS4,missense,TRG_LysEnd_APsAcLL_1,109-114,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs540065111,STX11,missense,TRG_LysEnd_APsAcLL_1,210-215,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs548101215,UNC13D,missense,TRG_LysEnd_APsAcLL_1,706-711,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs557976553,NPHS1,missense,TRG_LysEnd_APsAcLL_1,661-666,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs200949139,PINK1,missense,TRG_LysEnd_APsAcLL_1,312-317,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs531074742,MYH7B,missense,TRG_LysEnd_APsAcLL_1,1363-1368,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs144839980,MTR,missense,TRG_LysEnd_APsAcLL_1,352-357,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs201709367,NOD2,missense,TRG_LysEnd_APsAcLL_1,685-690,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs104895427,NOD2,missense,TRG_LysEnd_APsAcLL_1,310-315,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs183387506,CEP290,missense,TRG_LysEnd_APsAcLL_1,2354-2359,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs201003237,LAMB3,missense,TRG_LysEnd_APsAcLL_1,886-891,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs201003237,LAMB3,missense,TRG_LysEnd_APsAcLL_1,887-892,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs74315352,PARK7,missense,TRG_LysEnd_APsAcLL_1,147-152,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs35336155,USH1C,missense,TRG_LysEnd_APsAcLL_1,313-318,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs113941736,CEP41,missense,LIG_FHA_2,236-242,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs201831535,SCN5A,missense,LIG_FHA_2,1036-1042,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs140918872,NOD2,missense,LIG_FHA_2,387-393,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs148215666,LAMA1,missense,LIG_FHA_2,2023-2029,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs150062967,LRRK2,missense,LIG_FHA_2,2492-2498,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs61736441,MTR,missense,LIG_FHA_2,225-231,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs568347441,C10orf2,missense,LIG_FHA_2,494-500,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs138072724,BBS9,missense,LIG_FHA_2,426-432,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs138794842,FZD4,missense,LIG_FHA_2,184-190,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs144249951,LAMB3,missense,LIG_FHA_2,521-527,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs200428510,BMPR2,missense,LIG_FHA_2,626-632,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs536569775,CHD7,missense,LIG_FHA_2,2640-2646,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs150073296,FGA,missense,LIG_FHA_2,759-765,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs191246968,CEP41,missense,LIG_FHA_2,236-242,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs147500559,DFNB31,missense,LIG_FHA_2,353-359,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs114040223,LAMB3,missense,LIG_FHA_2,1039-1045,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs151275559,LAMA1,missense,LIG_FHA_2,1304-1310,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs16957538,BBS2,missense,LIG_FHA_2,500-506,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs549481773,F5,missense,LIG_FHA_2,2024-2030,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs34620165,BBS4,missense,LIG_FHA_2,246-252,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs137900287,KAL1,missense,LIG_FHA_2,586-592,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs144839980,MTR,missense,LIG_FHA_2,347-353,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs201050491,NPHS2,missense,LIG_FHA_2,61-67,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs201556325,F5,missense,LIG_FHA_2,1683-1689,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs554887705,NOD2,missense,LIG_FHA_2,387-393,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs199988202,HFE,missense,LIG_FHA_2,102-108,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs142153692,KCNE2,missense,LIG_FHA_2,8-14,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs540263945,MYH7,missense,LIG_FHA_2,1249-1255,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs531250955,MYH7,missense,LIG_FHA_2,1737-1743,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs140716236,NOD2,missense,LIG_FHA_2,387-393,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs148425972,SLC26A4,missense,LIG_FHA_2,371-377,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs143264522,UNC13D,missense,LIG_FHA_2,760-766,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs536728645,SGCB,missense,LIG_FHA_2,180-186,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs55774500,PARK2,missense,LIG_FHA_2,81-87,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs202197761,SCN5A,missense,LIG_FHA_2,1365-1371,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs145966037,RET,missense,LIG_FHA_2,454-460,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs573410951,LAMB3,missense,LIG_FHA_2,906-912,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs183007628,RBM20,missense,LIG_FHA_2,529-535,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs61737395,KCNA5,missense,LIG_FHA_2,28-34,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs374655803,MYO7A,missense,LIG_SH2_PTP2,1668-1671,,ELME000083,SH2 ligand,SH-PTP2 and phospholipase C-gamma Src Homology 2 (SH2) domains binding motif.,(Y)[IV].[VILP],0.0002453931,1,0
rs548208395,SLC26A4,missense,TRG_NLS_Bipartite_1,563-584,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs201863784,DSP,missense,TRG_NLS_Bipartite_1,2449-2467,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs201863784,DSP,missense,TRG_NLS_Bipartite_1,2450-2467,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs148508128,GDAP1,missense,TRG_NLS_Bipartite_1,172-194,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs553589945,SCN2A,missense,TRG_NLS_Bipartite_1,1018-1035,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs553589945,SCN2A,missense,TRG_NLS_Bipartite_1,1019-1035,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs542420576,SCN1A,missense,TRG_NLS_Bipartite_1,1027-1044,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs542420576,SCN1A,missense,TRG_NLS_Bipartite_1,1028-1044,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs192378817,MYO7A,missense,TRG_NLS_Bipartite_1,1103-1122,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs144199299,GDAP1,missense,TRG_NLS_Bipartite_1,172-194,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs143273384,ATP2B3,missense,LIG_TYR_ITSM,491-498,,ELME000142,Immunoreceptor tyrosine-based motif,"ITSM (immunoreceptor tyrosine-based switch motif). This motif is present in the cytoplasmic region of the CD150 subfamily within the CD2 family and it enables these receptors to bind to and to be regulated by SH2 adaptor molecules, as SH2DIA.",..T.(Y)..[IV],6.09445094958e-05,12,0
rs543621728,CEP290,missense,DOC_PP2A_B56_1,1325-1331,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs309369,BBS12,missense,DOC_PP2A_B56_1,120-126,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs556237236,LMNA,missense,DOC_PP2A_B56_1,106-112,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs563422939,LRRK2,missense,DOC_PP2A_B56_1,1095-1101,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs557905773,CYP1B1,missense,DOC_PP2A_B56_1,382-388,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs200428510,BMPR2,missense,DOC_PP2A_B56_1,626-631,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs143175221,HFE,missense,DOC_PP2A_B56_1,293-298,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs536814318,HMBS,missense,DOC_PP2A_B56_1,174-180,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs559363120,PYGM,missense,DOC_PP2A_B56_1,733-738,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs58073789,ABCC6,missense,DOC_PP2A_B56_1,722-728,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs199988202,HFE,missense,DOC_PP2A_B56_1,102-107,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs138366708,JUP,missense,DOC_PP2A_B56_1,686-691,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs113861754,UNC13D,missense,DOC_PP2A_B56_1,778-784,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs561602415,SLC45A2,missense,DOC_PP2A_B56_1,443-448,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs78387970,RNF216,missense,DOC_PP2A_B56_1,209-215,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs566081370,SCN1A,missense,DOC_PP2A_B56_1,1211-1216,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs140406696,PRPH2,missense,DOC_PP2A_B56_1,271-277,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs200433530,JUP,missense,MOD_NEK2_2,372-377,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs184636161,KCNQ1,missense,MOD_NEK2_2,461-466,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs141499220,UNC13D,missense,MOD_NEK2_2,296-301,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs143092783,NPHS1,missense,MOD_NEK2_2,1138-1143,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs150880478,TTC8,missense,MOD_NEK2_2,90-95,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs150036969,ABCC9,missense,MOD_NEK2_2,627-632,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs201891641,LAMA1,missense,DEG_Kelch_Keap1_1,1008-1013,,ELME000390,KEAP1 binding degron,Motif that binds to the Kelch domain of KEAP1 with high affinity. This high affinity motif is required for the efficient recruitment of target proteins to the Cul3-based E3 ligase.,[DNS].[DES][TNS]GE,5.95038132581e-05,13,4
rs575143221,STXBP2,missense,CLV_PCSK_SKI1_1,20-24,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs200453921,RNF216,missense,CLV_PCSK_SKI1_1,870-874,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs555797304,KCNH2,missense,CLV_PCSK_SKI1_1,1069-1073,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs539587517,DSP,missense,CLV_PCSK_SKI1_1,1637-1641,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs57179857,ABCC6,missense,CLV_PCSK_SKI1_1,1018-1022,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs144696430,BBS4,missense,CLV_PCSK_SKI1_1,109-113,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs200532195,F5,missense,CLV_PCSK_SKI1_1,337-341,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs559412676,PINK1,missense,CLV_PCSK_SKI1_1,246-250,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs551000865,NEK1,missense,CLV_PCSK_SKI1_1,410-414,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs569221128,RAB27A,missense,CLV_PCSK_SKI1_1,141-145,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs111033360,GJB2,missense,CLV_PCSK_SKI1_1,165-169,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs61754402,PRPH2,missense,CLV_PCSK_SKI1_1,12-16,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs192018835,MYO7A,missense,CLV_PCSK_SKI1_1,1967-1971,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs541330074,RBM20,missense,CLV_PCSK_SKI1_1,619-623,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs59588658,ABCC6,missense,CLV_PCSK_SKI1_1,1414-1418,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs148352106,RNF216,missense,CLV_PCSK_SKI1_1,870-874,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs151275559,LAMA1,missense,CLV_PCSK_SKI1_1,1303-1307,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs573272388,POLG,missense,CLV_PCSK_SKI1_1,1117-1121,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs200350065,ABCC9,missense,CLV_PCSK_SKI1_1,1330-1334,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs138777930,LRP5,missense,CLV_PCSK_SKI1_1,752-756,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs376754645,MYH7,missense,CLV_PCSK_SKI1_1,783-787,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs138893547,CPT2,missense,CLV_PCSK_SKI1_1,654-658,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs577415094,NEK1,missense,CLV_PCSK_SKI1_1,17-21,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs367976914,NPHS1,missense,CLV_PCSK_SKI1_1,606-610,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs189014161,KCNH2,missense,CLV_PCSK_SKI1_1,744-748,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs201513398,BBS12,missense,CLV_PCSK_SKI1_1,534-538,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs373519764,MYO6,missense,CLV_PCSK_SKI1_1,393-397,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs578110162,MKKS,missense,CLV_PCSK_SKI1_1,31-35,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs201033964,RNF216,missense,CLV_PCSK_SKI1_1,100-104,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs146159244,CPT2,missense,CLV_PCSK_SKI1_1,69-73,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs144968313,UNC13D,missense,CLV_PCSK_SKI1_1,847-851,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs144199299,GDAP1,missense,CLV_PCSK_SKI1_1,190-194,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs200390101,GDAP1,missense,CLV_PCSK_SKI1_1,206-210,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs561518392,LAMA1,missense,DOC_PP2B_LxvP_1,1396-1399,,ELME000367,Calcineurin (PP2B)-docking motif LxvP,Docking motif in calcineurin substrates that binds at the interface of the catalytic CNA and regulatory CNB subunits.,L.[LIVAPM]P,0.0022963509,8,0
rs555340137,ABCC9,missense,DOC_PP2B_LxvP_1,465-468,,ELME000367,Calcineurin (PP2B)-docking motif LxvP,Docking motif in calcineurin substrates that binds at the interface of the catalytic CNA and regulatory CNB subunits.,L.[LIVAPM]P,0.0022963509,8,0
rs142293185,MYO7A,missense,DOC_PP2B_LxvP_1,1954-1957,,ELME000367,Calcineurin (PP2B)-docking motif LxvP,Docking motif in calcineurin substrates that binds at the interface of the catalytic CNA and regulatory CNB subunits.,L.[LIVAPM]P,0.0022963509,8,0
rs150880478,TTC8,missense,DOC_PP2B_LxvP_1,94-97,,ELME000367,Calcineurin (PP2B)-docking motif LxvP,Docking motif in calcineurin substrates that binds at the interface of the catalytic CNA and regulatory CNB subunits.,L.[LIVAPM]P,0.0022963509,8,0
rs112626848,CAV3,missense,DOC_PP2B_LxvP_1,80-83,,ELME000367,Calcineurin (PP2B)-docking motif LxvP,Docking motif in calcineurin substrates that binds at the interface of the catalytic CNA and regulatory CNB subunits.,L.[LIVAPM]P,0.0022963509,8,0
rs539390533,LAMB3,missense,DOC_PP2B_LxvP_1,919-922,,ELME000367,Calcineurin (PP2B)-docking motif LxvP,Docking motif in calcineurin substrates that binds at the interface of the catalytic CNA and regulatory CNB subunits.,L.[LIVAPM]P,0.0022963509,8,0
rs372132926,ABCC6,missense,LIG_eIF4E_1,350-356,,ELME000317,eIF4E binding motif,Motif binding to the dorsal surface of eIF4E.,Y....L[VILMF],0.0001891275,13,0
rs201510575,F5,missense,LIG_eIF4E_1,173-179,,ELME000317,eIF4E binding motif,Motif binding to the dorsal surface of eIF4E.,Y....L[VILMF],0.0001891275,13,0
rs546641348,SCN1A,missense,LIG_eIF4E_1,165-171,,ELME000317,eIF4E binding motif,Motif binding to the dorsal surface of eIF4E.,Y....L[VILMF],0.0001891275,13,0
rs116840776,CAV3,missense,LIG_eIF4E_1,70-76,,ELME000317,eIF4E binding motif,Motif binding to the dorsal surface of eIF4E.,Y....L[VILMF],0.0001891275,13,0
rs202039659,HNF1A,missense,LIG_eIF4E_1,512-518,,ELME000317,eIF4E binding motif,Motif binding to the dorsal surface of eIF4E.,Y....L[VILMF],0.0001891275,13,0
rs531537646,LAMA1,missense,LIG_LIR_LC3C_4,699-702,,ELME000371,Atg8 protein family ligands,Non-canonical variant of the LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}LVV",0.0001368611,1,1
rs570913507,F5,missense,LIG_TRAF6,132-140,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs575608844,HMBS,missense,LIG_TRAF6,206-214,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs542557411,STXBP2,missense,LIG_TRAF6,460-468,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs562257866,SLC3A1,missense,LIG_TRAF6,83-91,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs557506252,HMBS,missense,LIG_TRAF6,206-214,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs140683387,BMPR2,missense,LIG_TRAF6,89-97,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs560126604,UNC13D,missense,LIG_TRAF6,164-172,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs140625362,LAMA1,missense,LIG_TRAF6,594-602,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs1800574,HNF1A,missense,LIG_TRAF6,92-100,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs146685108,STXBP2,missense,LIG_TRAF6,460-468,,ELME000133,TRAF6 binding site,TRAF6 binding site. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmatic tails.,..P.E..[FYWHDE].,0.0017147188,20,0
rs144814658,SCN2A,missense,TRG_NLS_MonoCore_2,34-39,,ELME000270,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. Strong core version.,[^DE]((K[RK])|(RK))[KRP][KR][^DE],0.0002344852,17,1
rs201863784,DSP,missense,TRG_NLS_MonoCore_2,2461-2466,,ELME000270,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. Strong core version.,[^DE]((K[RK])|(RK))[KRP][KR][^DE],0.0002344852,17,1
rs144814658,SCN2A,missense,TRG_NLS_MonoExtC_3,34-40,,ELME000278,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. C-extended version.,[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))(([PKR])|([^DE][DE])),0.0007251821,18,2
rs61754402,PRPH2,missense,TRG_NLS_MonoExtC_3,10-15,,ELME000278,NLS classical Nuclear Localization Signals,Monopartite variant of the classical basically charged NLS. C-extended version.,[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))(([PKR])|([^DE][DE])),0.0007251821,18,2
rs182025062,OTUD4,missense,LIG_SH2_SRC,655-658,,ELME000081,SH2 ligand,Src-family Src Homology 2 (SH2) domains binding motif.,(Y)[QDEVAIL][DENPYHI][IPVGAHS],0.0008729371,23,1
rs547308774,RET,missense,LIG_SH2_SRC,52-55,,ELME000081,SH2 ligand,Src-family Src Homology 2 (SH2) domains binding motif.,(Y)[QDEVAIL][DENPYHI][IPVGAHS],0.0008729371,23,1
rs147231991,TMPRSS3,missense,LIG_SH2_SRC,137-140,,ELME000081,SH2 ligand,Src-family Src Homology 2 (SH2) domains binding motif.,(Y)[QDEVAIL][DENPYHI][IPVGAHS],0.0008729371,23,1
rs201117517,WNT10A,missense,LIG_SH2_SRC,134-137,,ELME000081,SH2 ligand,Src-family Src Homology 2 (SH2) domains binding motif.,(Y)[QDEVAIL][DENPYHI][IPVGAHS],0.0008729371,23,1
rs577102638,CEP41,missense,LIG_SH2_SRC,23-26,,ELME000081,SH2 ligand,Src-family Src Homology 2 (SH2) domains binding motif.,(Y)[QDEVAIL][DENPYHI][IPVGAHS],0.0008729371,23,1
rs372085398,PCDH15,missense,DEG_Nend_Nbox_1,1-3,,ELME000355,N-degron,N-terminal motif that initiates protein degradation by binding to the N-box of N-recognins. This N-degron variant comprises N-terminal a bulky hydrophobic residue as destabilizing residue.,"^M{0,1}[FYLIW][^P]",0.0002302164,0,0
rs200163249,CCDC28B,missense,LIG_NRBOX,94-100,,ELME000045,Nuclear receptor box,The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.,[^P]L[^P][^P]LL[^P],0.0002627645,24,5
rs146858871,NPHS1,missense,LIG_NRBOX,1068-1074,,ELME000045,Nuclear receptor box,The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.,[^P]L[^P][^P]LL[^P],0.0002627645,24,5
rs540699814,DFNB31,missense,LIG_NRBOX,462-468,,ELME000045,Nuclear receptor box,The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.,[^P]L[^P][^P]LL[^P],0.0002627645,24,5
rs531074742,MYH7B,missense,LIG_NRBOX,1363-1369,,ELME000045,Nuclear receptor box,The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.,[^P]L[^P][^P]LL[^P],0.0002627645,24,5
rs537456337,GGCX,missense,LIG_NRBOX,367-373,,ELME000045,Nuclear receptor box,The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.,[^P]L[^P][^P]LL[^P],0.0002627645,24,5
rs202170315,LRRK2,missense,LIG_NRBOX,373-379,,ELME000045,Nuclear receptor box,The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.,[^P]L[^P][^P]LL[^P],0.0002627645,24,5
rs200664061,SLC26A4,missense,LIG_CaM_IQ_9,726-741,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs199988999,SCN1A,missense,LIG_CaM_IQ_9,1919-1935,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs17154353,SLC26A4,missense,LIG_CaM_IQ_9,726-741,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs533027065,MYO7A,missense,LIG_CaM_IQ_9,817-833,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs556589392,KCNQ1,missense,LIG_CaM_IQ_9,352-368,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs376754645,MYH7,missense,LIG_CaM_IQ_9,785-800,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs558502886,KCNJ10,missense,LIG_CaM_IQ_9,208-224,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs530647574,DSP,missense,LIG_CaM_IQ_9,1556-1572,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs529251704,MYO7A,missense,LIG_CaM_IQ_9,840-856,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs147276580,CPT2,missense,LIG_CaM_IQ_9,445-461,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs190761354,ABCC6,missense,CLV_MEL_PAP_1,592-598,,ELME000172,Melanisation activation site,Prophenoloxidase-activating proteinase (PAP) cleavage site ([ILV]-X-X-R-|-[FV]-[GS]-X).,[ILV]..R[VF][GS].,0.0001053756,12,0
rs574303164,ABCC6,missense,CLV_MEL_PAP_1,1044-1050,,ELME000172,Melanisation activation site,Prophenoloxidase-activating proteinase (PAP) cleavage site ([ILV]-X-X-R-|-[FV]-[GS]-X).,[ILV]..R[VF][GS].,0.0001053756,12,0
rs201793759,NEK1,missense,DEG_APCC_DBOX_1,476-484,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs201700546,DSP,missense,DEG_APCC_DBOX_1,770-778,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs568913937,POLG,missense,DEG_APCC_DBOX_1,627-635,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs568743605,JUP,missense,DEG_APCC_DBOX_1,215-223,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs367976914,NPHS1,missense,DEG_APCC_DBOX_1,605-613,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs572718618,BBS7,missense,DEG_APCC_DBOX_1,67-75,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs72549382,CYP1B1,missense,DEG_APCC_DBOX_1,313-321,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs201553621,KRT5,missense,DEG_APCC_DBOX_1,226-234,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs529251704,MYO7A,missense,DEG_APCC_DBOX_1,833-841,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs72480442,CYP1B1,missense,DEG_APCC_DBOX_1,365-373,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs79204362,CYP1B1,missense,DEG_APCC_DBOX_1,365-373,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs541560189,JUP,missense,LIG_PTB_Apo_2,278-285,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs543942826,NPHS1,missense,LIG_PTB_Apo_2,398-405,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs201733523,TACR3,missense,LIG_PTB_Apo_2,123-130,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs536486113,RET,missense,LIG_PTB_Apo_2,1056-1063,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs4252303,IL10RA,missense,LIG_PTB_Apo_2,112-119,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs201267913,CAV3,missense,LIG_PTB_Apo_2,127-134,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs200033170,UNC13D,missense,LIG_PTB_Apo_2,194-201,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs186298636,RNF216,missense,LIG_PTB_Apo_2,113-120,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs147494464,CEP41,missense,LIG_PTB_Apo_2,6-13,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs200513114,ABCC6,missense,LIG_PTB_Apo_2,707-714,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs200800189,ABCC6,missense,LIG_PTB_Apo_2,707-714,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs368802003,DSP,missense,LIG_BIR_II_1,1-5,,ELME000285,IAP-binding motif (IBM),These IBMs are found in pro-apoptotic proteins and function in the abrogation of caspase inhibition by Inhibitor of Apoptosis Proteins (IAPs) in apoptotic cells. The motif binds specifically to type II BIR domains.,"^M{0,1}[AS]...",0.0003252018,0,0
rs572277602,SLC3A1,missense,LIG_BIR_II_1,1-5,,ELME000285,IAP-binding motif (IBM),These IBMs are found in pro-apoptotic proteins and function in the abrogation of caspase inhibition by Inhibitor of Apoptosis Proteins (IAPs) in apoptotic cells. The motif binds specifically to type II BIR domains.,"^M{0,1}[AS]...",0.0003252018,0,0
rs199565370,PYGM,missense,LIG_BIR_II_1,1-5,,ELME000285,IAP-binding motif (IBM),These IBMs are found in pro-apoptotic proteins and function in the abrogation of caspase inhibition by Inhibitor of Apoptosis Proteins (IAPs) in apoptotic cells. The motif binds specifically to type II BIR domains.,"^M{0,1}[AS]...",0.0003252018,0,0
rs142885240,DSP,missense,CLV_C14_Caspase3-7,1739-1743,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs539587517,DSP,missense,CLV_C14_Caspase3-7,1638-1642,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs201240407,MFN2,missense,CLV_C14_Caspase3-7,496-500,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs568275152,CPOX,missense,CLV_C14_Caspase3-7,267-271,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs150073296,FGA,missense,CLV_C14_Caspase3-7,761-765,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs569249595,HNF1A,missense,DOC_CKS1_1,344-349,,ELME000358,Cks1 ligand,Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.,[MPVLIFWYQ].(T)P..,0.0019914638,8,1
rs201831535,SCN5A,missense,DOC_CKS1_1,1036-1041,,ELME000358,Cks1 ligand,Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.,[MPVLIFWYQ].(T)P..,0.0019914638,8,1
rs61340537,ABCC6,missense,DOC_CKS1_1,942-947,,ELME000358,Cks1 ligand,Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.,[MPVLIFWYQ].(T)P..,0.0019914638,8,1
rs115737075,RNF216,missense,DOC_CKS1_1,46-51,,ELME000358,Cks1 ligand,Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.,[MPVLIFWYQ].(T)P..,0.0019914638,8,1
rs189794855,KCNQ1,missense,DOC_CKS1_1,496-501,,ELME000358,Cks1 ligand,Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.,[MPVLIFWYQ].(T)P..,0.0019914638,8,1
rs150232968,PYGM,missense,DOC_CKS1_1,227-232,,ELME000358,Cks1 ligand,Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.,[MPVLIFWYQ].(T)P..,0.0019914638,8,1
rs150587582,BBS10,missense,DOC_USP7_UBL2_3,295-299,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs574459300,F5,missense,DOC_USP7_UBL2_3,327-331,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs574977655,CCDC28B,missense,DOC_USP7_UBL2_3,54-58,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs61754402,PRPH2,missense,DOC_USP7_UBL2_3,11-15,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs367987327,DSP,missense,DOC_USP7_UBL2_3,474-478,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs200706874,SLC26A4,missense,DOC_USP7_UBL2_3,77-81,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs533310932,BMPR2,missense,DOC_USP7_UBL2_3,671-675,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs529984825,UNC13D,missense,DOC_USP7_UBL2_3,231-235,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs556568897,CCDC28B,missense,DOC_USP7_UBL2_3,54-58,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs372685495,BBS7,missense,LIG_SH2_STAT3,445-448,,ELME000163,SH2 ligand,YXXQ motif found in the cytoplasmic region of cytokine receptors that bind STAT3 SH2 domain.,(Y)..Q,0.0007974958,9,0
rs547665147,CEP290,missense,LIG_SH2_STAT3,204-207,,ELME000163,SH2 ligand,YXXQ motif found in the cytoplasmic region of cytokine receptors that bind STAT3 SH2 domain.,(Y)..Q,0.0007974958,9,0
rs201026048,PCDH15,missense,MOD_SUMO_for_1,147-150,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs530342996,CEP290,missense,MOD_SUMO_for_1,1920-1923,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs535146522,CEP290,missense,MOD_SUMO_for_1,308-311,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs45496496,MYH7,missense,MOD_SUMO_for_1,962-965,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs377651588,COL17A1,missense,MOD_SUMO_for_1,402-405,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs201800075,MYH7B,missense,MOD_SUMO_for_1,1776-1779,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs199608117,PDZD7,missense,LIG_BIR_III_4,375-379,,ELME000293,IAP-binding motif (IBM),These IBMs are found in the N-terminal regions of arthropodal caspase subunits where they mediate the inhibition of activated caspases by binding to conserved surface grooves on type III BIR domains of Inhibitor of Apoptosis Proteins (IAPs).,DA.G.,0.0002753763,2,0
rs139719799,BBS10,missense,LIG_TYR_ITIM,557-562,,ELME000020,Immunoreceptor tyrosine-based motif,"ITIM (immunoreceptor tyrosine-based inhibitory motif). Phosphorylation of the ITIM motif, found in the cytoplasmic tail of some inhibitory receptors (KIRs) that bind MHC Class I, leads to the recruitment and activation of a protein tyrosine phosphatase.",[ILV].(Y)..[ILV],0.000299241,7,0
rs121917910,SCN1A,missense,LIG_TYR_ITIM,1304-1309,,ELME000020,Immunoreceptor tyrosine-based motif,"ITIM (immunoreceptor tyrosine-based inhibitory motif). Phosphorylation of the ITIM motif, found in the cytoplasmic tail of some inhibitory receptors (KIRs) that bind MHC Class I, leads to the recruitment and activation of a protein tyrosine phosphatase.",[ILV].(Y)..[ILV],0.000299241,7,0
rs35641839,MYO7A,missense,LIG_TYR_ITIM,674-679,,ELME000020,Immunoreceptor tyrosine-based motif,"ITIM (immunoreceptor tyrosine-based inhibitory motif). Phosphorylation of the ITIM motif, found in the cytoplasmic tail of some inhibitory receptors (KIRs) that bind MHC Class I, leads to the recruitment and activation of a protein tyrosine phosphatase.",[ILV].(Y)..[ILV],0.000299241,7,0
rs533282672,CPT2,missense,LIG_SH3_2,18-23,,ELME000006,SH3 ligand,This is the motif recognized by class II SH3 domains,P..P.[KR],0.0011112416,19,6
rs201968813,RNF216,missense,LIG_SH3_2,865-870,,ELME000006,SH3 ligand,This is the motif recognized by class II SH3 domains,P..P.[KR],0.0011112416,19,6
rs540032875,NEK1,missense,DOC_MAPK_RevD_3,110-123,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs17466213,LRRK2,missense,DOC_MAPK_RevD_3,1369-1384,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs201267913,CAV3,missense,DOC_MAPK_RevD_3,134-149,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs542835031,KCNE2,missense,DOC_MAPK_RevD_3,62-76,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs542835031,KCNE2,missense,DOC_MAPK_RevD_3,63-76,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs61755767,PRPH2,missense,DOC_MAPK_RevD_3,32-47,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs200532195,F5,missense,MOD_PKA_1,337-343,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs573249154,STX11,missense,MOD_PKA_1,77-83,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs113542001,ABCC9,missense,MOD_PKA_1,632-638,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs192378817,MYO7A,missense,MOD_PKA_1,1117-1123,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs561265847,LMBRD1,missense,TRG_ER_diArg_1,404-407,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs555879351,SCN5A,missense,TRG_ER_diArg_1,985-988,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs555879351,SCN5A,missense,TRG_ER_diArg_1,986-989,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs538845625,BMPR2,missense,TRG_ER_diArg_1,535-537,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs541139673,MYO7A,missense,TRG_ER_diArg_1,814-817,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs150924946,LMNA,missense,TRG_ER_diArg_1,296-299,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs201863784,DSP,missense,TRG_ER_diArg_1,2461-2464,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs573249154,STX11,missense,TRG_ER_diArg_1,77-79,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs117221419,UNC13D,missense,TRG_ER_diArg_1,410-412,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs528755232,CDH23,missense,TRG_ER_diArg_1,546-549,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs201003237,LAMB3,missense,TRG_ER_diArg_1,886-889,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs201003237,LAMB3,missense,TRG_ER_diArg_1,887-890,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs150245955,GJB3,missense,TRG_ER_diArg_1,103-106,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs370462053,WNT10A,missense,TRG_ER_diArg_1,241-244,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs139222212,F5,missense,CLV_NRD_NRD_1,706-708,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs538845625,BMPR2,missense,CLV_NRD_NRD_1,535-537,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs59588658,ABCC6,missense,CLV_NRD_NRD_1,1417-1419,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs371316424,LRRK2,missense,CLV_NRD_NRD_1,771-773,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs201863784,DSP,missense,CLV_NRD_NRD_1,2461-2463,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs573249154,STX11,missense,CLV_NRD_NRD_1,77-79,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs549888974,OTUD4,missense,CLV_NRD_NRD_1,446-448,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs143708308,SLC26A4,missense,CLV_NRD_NRD_1,713-715,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs140934960,USH1C,missense,CLV_NRD_NRD_1,356-358,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs529984825,UNC13D,missense,CLV_NRD_NRD_1,233-235,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs150245955,GJB3,missense,CLV_NRD_NRD_1,103-105,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs555879351,SCN5A,missense,LIG_SH3_1,986-992,,ELME000005,SH3 ligand,This is the motif recognized by class I SH3 domains,[RKY]..P..P,0.0012369823,5,0
rs549370363,FOXC1,missense,LIG_SH3_1,199-205,,ELME000005,SH3 ligand,This is the motif recognized by class I SH3 domains,[RKY]..P..P,0.0012369823,5,0
rs551155761,DFNB31,missense,LIG_SH3_1,580-586,,ELME000005,SH3 ligand,This is the motif recognized by class I SH3 domains,[RKY]..P..P,0.0012369823,5,0
rs574977655,CCDC28B,missense,CLV_PCSK_KEX2_1,54-56,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs538845625,BMPR2,missense,CLV_PCSK_KEX2_1,535-537,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs61754402,PRPH2,missense,CLV_PCSK_KEX2_1,12-14,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs573249154,STX11,missense,CLV_PCSK_KEX2_1,77-79,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs578110162,MKKS,missense,CLV_PCSK_KEX2_1,30-32,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs150245955,GJB3,missense,CLV_PCSK_KEX2_1,103-105,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs556568897,CCDC28B,missense,CLV_PCSK_KEX2_1,54-56,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs144199299,GDAP1,missense,CLV_PCSK_KEX2_1,190-192,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs574977655,CCDC28B,missense,CLV_PCSK_PC1ET2_1,54-56,,ELME000100,PCSK cleavage site,NEC1/NEC2 cleavage site (K-R-|-X).,KR.,0.0039027683,6,0
rs61754402,PRPH2,missense,CLV_PCSK_PC1ET2_1,12-14,,ELME000100,PCSK cleavage site,NEC1/NEC2 cleavage site (K-R-|-X).,KR.,0.0039027683,6,0
rs578110162,MKKS,missense,CLV_PCSK_PC1ET2_1,30-32,,ELME000100,PCSK cleavage site,NEC1/NEC2 cleavage site (K-R-|-X).,KR.,0.0039027683,6,0
rs556568897,CCDC28B,missense,CLV_PCSK_PC1ET2_1,54-56,,ELME000100,PCSK cleavage site,NEC1/NEC2 cleavage site (K-R-|-X).,KR.,0.0039027683,6,0
rs144199299,GDAP1,missense,CLV_PCSK_PC1ET2_1,190-192,,ELME000100,PCSK cleavage site,NEC1/NEC2 cleavage site (K-R-|-X).,KR.,0.0039027683,6,0
rs574977655,CCDC28B,missense,CLV_PCSK_PC7_1,50-56,,ELME000103,PCSK cleavage site,"Proprotein convertase 7 (PC7, PCSK7) cleavage site (R-X-X-X-[RK]-R-|-X).",R...[KR]R.,0.0005087229,1,0
rs556568897,CCDC28B,missense,CLV_PCSK_PC7_1,50-56,,ELME000103,PCSK cleavage site,"Proprotein convertase 7 (PC7, PCSK7) cleavage site (R-X-X-X-[RK]-R-|-X).",R...[KR]R.,0.0005087229,1,0
rs542258150,PINK1,missense,CLV_PCSK_PC7_1,492-498,,ELME000103,PCSK cleavage site,"Proprotein convertase 7 (PC7, PCSK7) cleavage site (R-X-X-X-[RK]-R-|-X).",R...[KR]R.,0.0005087229,1,0
rs4640000,LRRK2,missense,LIG_Rb_LxCxE_1,1259-1280,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs543376293,RET,missense,LIG_Rb_LxCxE_1,522-542,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs577589879,PYGM,missense,LIG_Rb_LxCxE_1,777-799,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs577589879,PYGM,missense,LIG_Rb_LxCxE_1,779-799,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs577589879,PYGM,missense,LIG_Rb_LxCxE_1,780-799,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs56264519,TMPRSS3,missense,LIG_Rb_LxCxE_1,419-439,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs56264519,TMPRSS3,missense,LIG_Rb_LxCxE_1,420-439,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs114904237,TMPRSS3,missense,LIG_Rb_LxCxE_1,419-439,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs114904237,TMPRSS3,missense,LIG_Rb_LxCxE_1,420-439,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
rs111903177,WNT10A,missense,MOD_OFUCOSY,271-276,,ELME000162,O-Fucosylation site,Site for attachment of a fucose residue to a serine.,"C.{3,5}([ST])C",4.61694301554e-05,4,0
rs114544692,LAMB3,missense,MOD_OFUCOSY,796-801,,ELME000162,O-Fucosylation site,Site for attachment of a fucose residue to a serine.,"C.{3,5}([ST])C",4.61694301554e-05,4,0
rs142948132,EDA,missense,LIG_SH3_4,327-334,,ELME000156,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class II recognition specificity,KP..[QK]...,0.000678138,2,0
rs200350065,ABCC9,missense,LIG_SH3_4,1326-1333,,ELME000156,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class II recognition specificity,KP..[QK]...,0.000678138,2,0
rs201985242,SCN1A,missense,LIG_SH3_4,38-45,,ELME000156,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class II recognition specificity,KP..[QK]...,0.000678138,2,0
rs561552566,ABCC6,missense,LIG_Pex14_1,506-510,,ELME000080,Pex14 ligand motif,Wxxx[FY] motifs present in N-terminal half of Pex5 bind to Pex13 and Pex14 at peroxisomal and glycosomal membranes to facilitate entrance of PTS1 cargo proteins into the organellar lumen.,W...[FY],0.000222625,27,1
rs146858871,NPHS1,missense,LIG_ANK_PxLPxL_1,1061-1069,,ELME000412,PxLPxI/L motif binding to some ANK repeat proteins,"The consensus PxLPxI/L motif, which can be found in diverse proteins, binds to the ankyrin repeat domains of ANKRA2 and its close paralog RFXANK.","P.LP.[IL].{1,3}[VLF]",2.67020539666e-05,10,5
rs200363767,MTR,missense,DEG_ODPH_VHL_1,1086-1099,,ELME000248,Hydroxyproline modification in hypoxia signaling,Oxygen dependent prolyl hydroxylation motif in the unstructured region of hypoxia-inducible factor protein and bound by the VHL ligand.,"[IL]A(P).{6,8}[FLIVM].[FLIVM]",7.03776543919e-05,8,1
rs567793250,NOD2,missense,LIG_RRM_PRI_1,18-25,,ELME000235,RRM domain ligands,"The PTB RRM2 Interacting (PRI) motif is found in some splicing regulators, possibly only in the chordate lineage. As part of splicing complex regulation, it interacts with the 2nd RNA binding domain (RRM) of PTB, the polypyrimidine tract binding protein.",.[ILVM]LG..P.,8.39114380548e-05,3,0
rs550799905,PRF1,missense,LIG_RRM_PRI_1,541-548,,ELME000235,RRM domain ligands,"The PTB RRM2 Interacting (PRI) motif is found in some splicing regulators, possibly only in the chordate lineage. As part of splicing complex regulation, it interacts with the 2nd RNA binding domain (RRM) of PTB, the polypyrimidine tract binding protein.",.[ILVM]LG..P.,8.39114380548e-05,3,0
rs530687764,NEK1,missense,LIG_SH2_GRB2,180-183,,ELME000084,SH2 ligand,GRB2-like Src Homology 2 (SH2) domains binding motif.,(Y).N.,0.000478687,16,3
rs147231991,TMPRSS3,missense,LIG_SH2_GRB2,137-140,,ELME000084,SH2 ligand,GRB2-like Src Homology 2 (SH2) domains binding motif.,(Y).N.,0.000478687,16,3
rs573426783,RBM20,missense,LIG_BIR_III_2,10-14,,ELME000287,IAP-binding motif (IBM),These IBMs are found at the N-terminal regions of caspase subunits where they mediate the inhibition of activated caspases by binding to conserved surface grooves on type III BIR domains of Inhibitor of Apoptosis Proteins (IAPs).,DA.P.,0.000351121,3,1
rs554615192,USH1C,missense,DOC_ANK_TNKS_1,91-98,,ELME000097,Tankyrase-binding motif,The Tankyrase binding motif interacts with the ankyrin repeat domain region in Tankyrase-1 and Tankyrase-2 to facilitate the PARsylation of the target proteins.,.R..[PGAV][DEIP]G.,0.0003537886,17,5
rs112600292,PINK1,missense,DOC_ANK_TNKS_1,301-308,,ELME000097,Tankyrase-binding motif,The Tankyrase binding motif interacts with the ankyrin repeat domain region in Tankyrase-1 and Tankyrase-2 to facilitate the PARsylation of the target proteins.,.R..[PGAV][DEIP]G.,0.0003537886,17,5
rs570284670,LAMA1,missense,TRG_AP2beta_CARGO_1,643-652,,ELME000247,AP-2 beta2 appendage CCV component motifs,AP-2 beta appendage platform subdomain (top surface) binding motif used in targeting cargo for internalisation.,"[DE].{1,2}F[^P][^P][FL][^P][^P][^P]R",1.81693308253e-05,4,2
rs191342808,RBM20,missense,LIG_EH_1,71-75,,ELME000056,EH ligand,"NPF motif interacting with EH domains, usually during regulation of endocytotic processes",.NPF.,5.86028045872e-05,88,3
rs549481773,F5,missense,DEG_APCC_KENBOX_2,2027-2031,,ELME000232,APCC-binding Destruction motifs,Motif conserving the exact sequence KEN that binds to the APC/C subunit Cdh1 causing the protein to be targeted for  26S proteasome mediated degradation.,.KEN.,0.000184312,16,1
rs547702101,CEP290,missense,DEG_APCC_KENBOX_2,275-279,,ELME000232,APCC-binding Destruction motifs,Motif conserving the exact sequence KEN that binds to the APC/C subunit Cdh1 causing the protein to be targeted for  26S proteasome mediated degradation.,.KEN.,0.000184312,16,1
rs200193213,LAMA1,missense,DEG_APCC_KENBOX_2,473-477,,ELME000232,APCC-binding Destruction motifs,Motif conserving the exact sequence KEN that binds to the APC/C subunit Cdh1 causing the protein to be targeted for  26S proteasome mediated degradation.,.KEN.,0.000184312,16,1
rs551155761,DFNB31,missense,LIG_EVH1_1,582-586,,ELME000057,EVH1  ligands,Proline-rich motif binding to signal transduction class I EVH1 domains.,([FYWL]P.PP)|([FYWL]PP[ALIVTFY]P),0.0001236754,19,3
rs536486113,RET,missense,LIG_PTB_Phospho_1,1056-1062,,ELME000095,PTB ligand,This phosphorylation-dependent motif binds to Shc-like and IRS-like PTB domains. The pTyr is positioned within a highly basic-charged anchoring pocket. A hydrophobic residue -5 (compared to pY) increases the affinity of the interaction.,(.[^P].NP.(Y))|(.[ILVMFY].N..(Y)),0.0001352405,17,6
rs147494464,CEP41,missense,LIG_PTB_Phospho_1,6-12,,ELME000095,PTB ligand,This phosphorylation-dependent motif binds to Shc-like and IRS-like PTB domains. The pTyr is positioned within a highly basic-charged anchoring pocket. A hydrophobic residue -5 (compared to pY) increases the affinity of the interaction.,(.[^P].NP.(Y))|(.[ILVMFY].N..(Y)),0.0001352405,17,6
rs137900287,KAL1,missense,DEG_MDM2_SWIB_1,585-592,,ELME000184,MDM2 binding motif,An amphipatic &alpha;-helix found in p53 family members that binds in the hydrophobic cleft of MDM2's SWIB domain.,"F[^P]{3}W[^P]{2,3}[VIL]",2.12465805842e-05,5,2
rs2066845,NOD2,missense,DEG_MDM2_SWIB_1,903-911,,ELME000184,MDM2 binding motif,An amphipatic &alpha;-helix found in p53 family members that binds in the hydrophobic cleft of MDM2's SWIB domain.,"F[^P]{3}W[^P]{2,3}[VIL]",2.12465805842e-05,5,2
rs201034266,LRRK2,missense,DOC_MAPK_NFAT4_5,1655-1663,,ELME000423,MAPK docking motifs,An extended D site specifically recognized by the JNK kinases ,[RK][^P][^P][LIM].L.[LIVMF].,0.000163458,17,1
rs143175221,HFE,missense,DOC_PP2B_PxIxI_1,291-297,,ELME000237,Calcineurin (PP2B)-docking motif PxIxI,"Calcineurin substrate docking site, leads to the effective dephosphorylation of serine/threonine phosphorylation sites.",.P[^P]I[^P][IV][^P],0.0001367857,10,2
rs199473303,SCN5A,missense,LIG_RGD,1739-1741,,ELME000094,Integrin binding sites,The RGD motif can be found in many proteins of the extracellular matrix and it is recognized by different members of the integrin family. The structure of the tenth type III module of fibronectin has  shown that the RGD motif lies on an exposed flexible lo,RGD,0.0002366175,21,1
rs557239500,PDZD7,missense,MOD_Cter_Amidation,404-407,,ELME000093,Peptide Amidation Site,Peptide C-terminal amidation,(.)G[RK][RK],0.0011550292,0,0
rs143853128,LAMA1,missense,MOD_Cter_Amidation,2067-2070,,ELME000093,Peptide Amidation Site,Peptide C-terminal amidation,(.)G[RK][RK],0.0011550292,0,0
rs201117517,WNT10A,missense,LIG_NBox_RRM_1,132-142,,ELME000346,FBP Nbox motif,"Amino terminal region on Far Upstream Element (FUSE) binding protein (UNIPROT:Q96AE4), which mediates the interaction with FIR in order to recruit FIR (UNIPROT:Q9UHX1) to FUSE DNA.",F..A[ILV]..A..[ILV],2.14199246297e-06,2,1
rs578110162,MKKS,missense,LIG_MAD2,31-39,,ELME000167,MAD2 binding motif,Mad2 binding motif,[KR][IV][LV].....P,0.0001010635,6,1
rs201804583,PRF1,missense,DEG_SCF_FBW7_1,133-140,,ELME000289,SCF ubiquitin ligase binding Phosphodegrons,The TPxxS phospho-dependent degron binds the FBW7 F box proteins of the SCF (Skp1_Cullin-Fbox) complex.,"[LIVMP].{0,2}(T)P..([ST])",0.0007138326,6,2
rs201804583,PRF1,missense,DEG_SCF_FBW7_1,135-140,,ELME000289,SCF ubiquitin ligase binding Phosphodegrons,The TPxxS phospho-dependent degron binds the FBW7 F box proteins of the SCF (Skp1_Cullin-Fbox) complex.,"[LIVMP].{0,2}(T)P..([ST])",0.0007138326,6,2
rs150245955,GJB3,missense,CLV_PCSK_FUR_1,101-105,,ELME000101,PCSK cleavage site,Furin (PACE) cleavage site (R-X-[RK]-R-|-X).,R.[RK]R.,0.0005087229,13,0
rs138018628,PINK1,missense,DEG_SPOP_SBC_1,226-230,,ELME000388,SPOP SBC docking motif,"The S/T rich motif known as the SPOP-binding consensus (SBC) of the MATH-BTB protein, SPOP, is present in substrates that undergo SPOP/Cul3-dependant ubiquitination.",[AVP].[ST][ST][ST],0.0009379629,8,6
rs200882666,KCNA5,missense,DEG_Nend_UBRbox_2,1-3,,ELME000352,N-degron,N-terminal motif that initiates protein degradation by binding to the UBR-box of N-recognins. This N-degron variant comprises N-terminal Asp or Glu as destabilizing residue.,"^M{0,1}([ED]).",0.0002537082,0,0
rs539390533,LAMB3,missense,LIG_CSL_BTD_1,919-922,,ELME000410,Ligand motif binding the CSL BTD,The motif mediates the interaction between a Notch-like protein and the transcription factor CSL by placing two amino acids (W and P) into a hydrophobic pocket of the BTD domain of CSL.,[AFILMPTVW]W[FHILMPSTVW]P,0.0001278426,18,2
rs201194028,BBS10,missense,MOD_LATS_1,119-125,,ELME000334,LATS kinase phosphorylation motif,The LATS phosphorylation motif is recognised by the LATS kinases for Ser/Thr phosphorylation. Substrates are often found toward the end of the Hippo signalling pathway.,H.[KR]..([ST])[^P],0.0004776462,23,0
